<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD004083.pub3" GROUP_ID="ANAESTH" ID="119402030514250991" MERGED_FROM="" MODIFIED="2015-06-26 13:44:49 +0100" MODIFIED_BY="Jane Cracknell" REVIEW_NO="046" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="6.0">
<COVER_SHEET MODIFIED="2015-06-26 13:44:49 +0100" MODIFIED_BY="Jane Cracknell">
<TITLE>Peribulbar versus retrobulbar anaesthesia for cataract surgery</TITLE>
<CONTACT MODIFIED="2015-06-26 13:44:49 +0100" MODIFIED_BY="Jane Cracknell"><PERSON ID="12541" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Mahmoud</FIRST_NAME><MIDDLE_INITIALS>B</MIDDLE_INITIALS><LAST_NAME>Alhassan</LAST_NAME><SUFFIX>MBBS, FWACS</SUFFIX><POSITION>Consultant</POSITION><EMAIL_1>mbalhassan@yahoo.com</EMAIL_1><ADDRESS><DEPARTMENT>Clinical Ophthalmology</DEPARTMENT><ORGANISATION>The National Eye Centre</ORGANISATION><ADDRESS_1>Western Bye Pass</ADDRESS_1><ADDRESS_2>Nnamdi Azikiwe Way</ADDRESS_2><CITY>Kaduna</CITY><ZIP>PMP 2267</ZIP><REGION>Kaduna State</REGION><COUNTRY CODE="NG">Nigeria</COUNTRY><PHONE_1>+234 62 311401</PHONE_1><PHONE_2>+234 62 315026</PHONE_2><FAX_1>+234 62 313954</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2015-06-26 13:44:49 +0100" MODIFIED_BY="Jane Cracknell"><PERSON ID="12541" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Mahmoud</FIRST_NAME><MIDDLE_INITIALS>B</MIDDLE_INITIALS><LAST_NAME>Alhassan</LAST_NAME><SUFFIX>MBBS, FWACS</SUFFIX><POSITION>Consultant</POSITION><EMAIL_1>mbalhassan@yahoo.com</EMAIL_1><ADDRESS><DEPARTMENT>Clinical Ophthalmology</DEPARTMENT><ORGANISATION>The National Eye Centre</ORGANISATION><ADDRESS_1>Western Bye Pass</ADDRESS_1><ADDRESS_2>Nnamdi Azikiwe Way</ADDRESS_2><CITY>Kaduna</CITY><ZIP>PMP 2267</ZIP><REGION>Kaduna State</REGION><COUNTRY CODE="NG">Nigeria</COUNTRY><PHONE_1>+234 62 311401</PHONE_1><PHONE_2>+234 62 315026</PHONE_2><FAX_1>+234 62 313954</FAX_1></ADDRESS></PERSON><PERSON ID="11256" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Fatima</FIRST_NAME><LAST_NAME>Kyari</LAST_NAME><SUFFIX>MBBS, FWACS</SUFFIX><POSITION>Consultant Ophthalmologist</POSITION><EMAIL_1>fatimaygk@gmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Clinical Ophthalmology</DEPARTMENT><ORGANISATION>The National Eye Centre</ORGANISATION><CITY>Kaduna</CITY><COUNTRY CODE="NG">Nigeria</COUNTRY></ADDRESS></PERSON><PERSON ID="18228" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Henry</FIRST_NAME><MIDDLE_INITIALS>OD</MIDDLE_INITIALS><LAST_NAME>Ejere</LAST_NAME><SUFFIX>MD, MBBS, MSc, FWACS</SUFFIX><POSITION>Medical Director</POSITION><EMAIL_1>hodejere2000@yahoo.com</EMAIL_1><ADDRESS><ORGANISATION>Hode Internal Medicine</ORGANISATION><ADDRESS_1>120 South Park Drive, Suite F</ADDRESS_1><ADDRESS_2>Brownwood</ADDRESS_2><CITY>Texas</CITY><ZIP>76801</ZIP><COUNTRY CODE="US">USA</COUNTRY></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2015-06-11 11:01:58 +0100" MODIFIED_BY="Jane Cracknell">
<UP_TO_DATE>
<DATE DAY="15" MONTH="3" YEAR="2015"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="15" MONTH="3" YEAR="2015"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="29" MONTH="3" YEAR="2017"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="2003"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="2008"/>
<LAST_CITATION_ISSUE ISSUE="6" YEAR="2015"/>
</DATES>
<WHATS_NEW MODIFIED="2015-06-26 13:43:45 +0100" MODIFIED_BY="Jane Cracknell">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2015-06-26 13:43:29 +0100" MODIFIED_BY="Jane Cracknell">
<DATE DAY="26" MONTH="6" YEAR="2015"/>
<DESCRIPTION>
<P>Search updated - no new studies found.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2015-06-26 13:43:45 +0100" MODIFIED_BY="Jane Cracknell">
<DATE DAY="26" MONTH="6" YEAR="2015"/>
<DESCRIPTION>
<P>In the previous updated version of our review (<LINK REF="REF-Alhassan-2008" TYPE="REFERENCE">Alhassan 2008</LINK>), we searched the databases until September 2010. In this current updated version we reran the database searches until March 2015. We did not find any new studies which fitted our inclusion criteria.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2015-06-11 11:02:06 +0100" MODIFIED_BY="Jane Cracknell">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2015-06-11 11:02:06 +0100" MODIFIED_BY="Jane Cracknell">
<DATE DAY="15" MONTH="3" YEAR="2011"/>
<DESCRIPTION>
<P>In the previous version of our review, we searched the databases until December 2007. In this updated version we reran the database searches until September 2010. We did not find any new studies which fitted our inclusion criteria. We updated our methods section and included risk of bias and summary of findings tables.</P>
<P> </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>National Eye Centre, Kaduna</NAME>
<COUNTRY CODE="NG">Nigeria</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>Cochrane Anaesthesia Review Group</NAME>
<COUNTRY CODE="DK">Denmark</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>UK Cochrane Centre</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Cochrane Eye and Vision Group</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2015-06-26 13:36:12 +0100" MODIFIED_BY="Jane Cracknell">
<SUMMARY MODIFIED="2011-03-11 09:31:24 +0000" MODIFIED_BY="[Empty name]">
<TITLE>Comparison of two forms of local anaesthesia for cataract surgery</TITLE>
<SUMMARY_BODY MODIFIED="2011-03-11 09:31:24 +0000" MODIFIED_BY="[Empty name]">
<P>Cataracts are the commonest cause of blindness, worldwide. A cataract is the clouding of the lens that causes loss of transparency of the eye. It is treated by removing the lens and replacing it with an artificial lens. Cataract surgery is usually performed under local anaesthetic, either peribulbar or retrobulbar anaesthesia. There is debate over whether the peribulbar approach provides more effective and safer anaesthesia for cataract surgery than retrobulbar block. Peribulbar anaesthesia is performed by injecting the anaesthetic drug in the orbit around the equator of the eye ball (globe). Retrobulbar anaesthesia is performed by injecting the anaesthetic drug in the orbit further back behind the eye ball, which is near the nerves that control eye movement and sensation.</P>
<P>We set out to compare the two forms of local anaesthesia for cataract surgery. Our review showed that pain control and paralysis of the eye muscles to paralyse movement of the eye ball (akinesia) and allow surgery are no different for the two types of anaesthesia. The need for additional injections of local anaesthetic was higher with peribulbar anaesthesia (four trials). Only one case of bleeding behind the eye occurred and this was with retrobulbar anaesthesia (in one trial). The acceptability of the two methods to patients were similar in the two studies that reported on this outcome. None of the trials reported any life-threatening complications. There was a moderate risk of bias in the included trials.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2015-06-11 01:52:02 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2011-03-11 09:16:25 +0000" MODIFIED_BY="[Empty name]">
<P>Cataract is a major cause of blindness worldwide. Unless medically contraindicated, cataract surgery is usually performed under local (regional) anaesthesia. Local anaesthesia involves the blockage of a nerve subserving a given part of the body. It involves infiltration of the area around the nerve with local anaesthetic. The two main approaches in the eye are retrobulbar and peribulbar. There is debate over whether the peribulbar approach provides more effective, safer anaesthesia for cataract surgery than retrobulbar block.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2008-04-05 00:49:01 +0100" MODIFIED_BY="[Empty name]">
<P>The objective of this review was to assess the effects of peribulbar anaesthesia (PB) compared to retrobulbar anaesthesia (RB) on pain scores, ocular akinesia, patient acceptability and ocular and systemic complications.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2015-06-11 01:52:02 +0100" MODIFIED_BY="[Empty name]">
<P>In the previous version of our review, we searched the databases until December 2007. In this updated version, we searched the Cochrane Central Register of Controlled Trials (CENTRAL) (March 2015); MEDLINE (1960 to March 2015); and EMBASE (1980 to March 2015).</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2008-03-17 13:14:39 +0000" MODIFIED_BY="Jane Cracknell">
<P>We included randomized controlled clinical trials comparing peribulbar anaesthesia and retrobulbar anaesthesia for cataract surgery.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2011-03-11 09:20:45 +0000" MODIFIED_BY="[Empty name]">
<P>Two authors independently assessed trial quality and extracted data. We contacted trial authors for additional information, study methodology and missing data. We carried out a descriptive narrative of results as the included studies used varied methods for reporting the outcomes. We performed a subgroup analysis for globe akinesia.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2011-03-16 11:44:02 +0000" MODIFIED_BY="Jane Cracknell">
<P>We included six trials involving 1438 participants. Three of the six trials had adequate sequence generation while all the trials had unclear allocation concealment There was no evidence of any difference in pain perception during surgery with either retrobulbar or peribulbar anaesthesia. Both were largely effective. There was no evidence of any difference in complete akinesia or the need for further injections of local anaesthetic. Conjunctival chemosis was more common after peribulbar block (relative risk (RR) 2.11, 95% confidence interval (CI) 1.46 to 3.05) and lid haematoma was more common after retrobulbar block (RR 0.36, 95% CI 0.15 to 0.88). Retrobulbar haemorrhage was uncommon and occurred only once, in a patient who had a retrobulbar block.<BR/>
</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2011-03-11 09:25:03 +0000" MODIFIED_BY="[Empty name]">
<P>There is little to choose between peribulbar and retrobulbar block in terms of anaesthesia and akinesia during surgery measuring acceptability to patients, need for additional injections and development of severe complications. Severe local or systemic complications were rare for both types of block.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2015-06-26 13:36:12 +0100" MODIFIED_BY="Jane Cracknell">
<BACKGROUND MODIFIED="2011-03-11 09:44:26 +0000" MODIFIED_BY="[Empty name]">
<P>Cataract is the loss of transparency of the crystalline human lens. Cataracts are the major cause of blindness, worldwide, and approximately 20 million people were believed to be blind from cataract in 1999 (<LINK REF="REF-Foster-1999" TYPE="REFERENCE">Foster 1999</LINK>). The commonest type of cataract is age related. Other causes include trauma, intraocular inflammation and heredity. As there are no well-documented, effective ways of preventing age-related cataract, all efforts are toward providing surgery to those who need it. Cataract surgery involves removing the cataractous lens and thereby relieving visual impairment. The lens can be completely removed (intracapsular cataract extraction) or partially removed with the posterior capsule of the lens remaining (extracapsular cataract extraction). The extracapsular technique permits insertion of an artificial intraocular lens.</P>
<P>Unless medically contraindicated, cataract surgery is usually performed under local (regional) anaesthesia. Local anaesthesia is the blockage of a nerve subserving a given part of the body by infiltrating the area around the nerve with local anaesthetic. In the eye, the periocular area is infiltrated to block all the nerves around the globe. The goal is safe, painless, efficient and effective local anaesthesia (<LINK REF="REF-Hamilton-1988" TYPE="REFERENCE">Hamilton 1988</LINK>). There are different approaches to the delivery of local injections to produce anaesthesia for cataract surgery. The two main approaches are retrobulbar and peribulbar. The retrobulbar approach appears to be more commonly practiced but there is an increasing tendency to use peribulbar anaesthesia, which is claimed to provide the same degree of akinesia and anaesthesia as retrobulbar injection (<LINK REF="STD-Hessemer-1994" TYPE="STUDY">Hessemer 1994</LINK>). Although newer techniques of administering local anaesthesia for cataract surgery, such as sub-tenons and topical or intracameral application, are gaining popularity, peribulbar or retrobulbar anaesthesia is still the technique of choice in several parts of the world (<LINK REF="REF-Hansen-1998" TYPE="REFERENCE">Hansen 1998</LINK>; <LINK REF="REF-Leaming-1999" TYPE="REFERENCE">Leaming 1999</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="2">Techniques</HEADING>
<SUBSECTION>
<HEADING LEVEL="3">Retrobulbar anaesthesia</HEADING>
<P>Retrobulbar anaesthesia (RB) is produced by delivering the local anaesthetic agent into the space behind the eye. This space is enclosed by the muscles that move the eye. It also contains the optic nerve, the nerves that control eye muscle contraction and the sensory nerves that supply sensation to the globe and its surrounding structures (<LINK REF="REF-Springs-2001" TYPE="REFERENCE">Springs 2001</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Peribulbar anaesthesia</HEADING>
<P>Peribulbar anaesthesia (PB) is given by delivering the local anaesthetic agent outside the muscle cone (<LINK REF="REF-Davis-1986" TYPE="REFERENCE">Davis 1986</LINK>; <LINK REF="REF-Fry-1990" TYPE="REFERENCE">Fry 1990</LINK>).</P>
<P>There is debate over whether the peribulbar approach provides more effective, safer anaesthesia for cataract surgery than does retrobulbar block. It is recognized that use of the retrobulbar approach may be associated with potentially serious ocular damage due to the blind insertion of a needle into the intraconal space. This is the space behind the eye, formed by the extraocular muscles, that contains the major nerves of the eye and its adnexa. The risks include scleral perforation, stimulation of the oculocardiac reflex and injection of anaesthetic agent into the perioptic meningeal space. However, this route may have the advantage of rapid onset of analgesia and akinesia with the use of relatively smaller volumes of anaesthetic agent (<LINK REF="STD-Ali_x002d_Melkkila-1992" TYPE="STUDY">Ali-Melkkila 1992</LINK>). Like the retrobulbar approach, peribulbar anaesthesia aims to ensure ocular akinesia (eye stability) and anaesthesia during surgery; it is considered by some to be safer than retrobulbar anaesthesia (<LINK REF="REF-Davis-1989" TYPE="REFERENCE">Davis 1989</LINK>; <LINK REF="STD-Murdoch-1990" TYPE="STUDY">Murdoch 1990;</LINK> <LINK REF="STD-Whitsett-1990" TYPE="STUDY">Whitsett 1990</LINK>). Peribulbar block is thought to be associated with fewer incidences of serious complications but may have a slower onset of anaesthesia and require larger volumes of anaesthetic agent. Both approaches, however, may have potentially sight and life-threatening complications (<LINK REF="REF-Davis-1994" TYPE="REFERENCE">Davis 1994</LINK>). This systematic review set out to summarize the best available evidence for the effects of peribulbar anaesthesia and retrobulbar anaesthesia for cataract surgery. Previous reviews were deficient in accounting for biases which may have been present in the clinical trials, thus making their findings unreliable. Friedman et al did an extensive review of the literature to assess the effectiveness of regional anaesthesia for cataract surgery but the review searched for trials only up to 1999 and did not assess the need for additional injections (<LINK REF="REF-Friedman-2001a" TYPE="REFERENCE">Friedman 2001a</LINK>; <LINK REF="REF-Friedman-2001b" TYPE="REFERENCE">Friedman 2001b</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</BACKGROUND>
<OBJECTIVES MODIFIED="2008-04-05 02:53:00 +0100" MODIFIED_BY="[Empty name]">
<P>The objective of this review was to assess the effects of peribulbar anaesthesia compared to retrobulbar anaesthesia on pain scores, ocular akinesia, patient acceptability and ocular and systemic complications.</P>
</OBJECTIVES>
<METHODS MODIFIED="2015-06-11 02:07:53 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2011-03-11 09:48:05 +0000" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2011-03-11 09:46:07 +0000" MODIFIED_BY="[Empty name]">
<P>We included randomized controlled clinical trials (RCTs) comparing retrobulbar block to peribulbar block for cataract surgery.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2008-03-14 05:57:22 +0000" MODIFIED_BY="[Empty name]">
<P>We included patients undergoing cataract surgery.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2011-03-11 09:46:34 +0000" MODIFIED_BY="[Empty name]">
<P>We included trials comparing peribulbar block to retrobulbar block for cataract surgery. Peribulbar block included all its various modifications, as described by <LINK REF="STD-Ali_x002d_Melkkila-1993" TYPE="STUDY">Ali-Melkkila 1993</LINK> and <LINK REF="REF-Davis-1989" TYPE="REFERENCE">Davis 1989</LINK>.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2011-03-11 09:48:05 +0000" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2011-03-11 09:47:33 +0000" MODIFIED_BY="[Empty name]">
<OL>
<LI>Pain: experienced during surgery and measured using a visual analogue scale (VAS) (1 to 10) or any other method as described in the primary report.</LI>
<LI>Ocular akinesia: the degree to which the ocular muscles were paralysed and the eye immobilized, i.e. complete akinesia.</LI>
<LI>Acceptability of block to patients: the number of participants who reported that the blocks were acceptable to them.</LI>
</OL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2011-03-11 09:48:05 +0000" MODIFIED_BY="[Empty name]">
<OL>
<LI>Need for supplemental injection (of local anaesthetic): the number of additional injections given in order to achieve good akinesia.</LI>
<LI>Complications of the procedure as reported by the primary investigators and classified into:</LI>
<OL>
<LI>local complications measured as the number of participants in whom local complications were observed during or after administration of a local anaesthetic (examples include retrobulbar haemorrhage, globe perforation, optic nerve damage, raised orbital pressure);</LI>
<LI>systemic complications measured as the number of participants in whom systemic complications arose during or after administration of a local anaesthetic (examples include respiratory depression, cardiopulmonary arrest).</LI>
</OL>
</OL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2015-06-11 01:54:12 +0100" MODIFIED_BY="[Empty name]">
<P>In the previous version of our review, we searched all the databases until December 2007.</P>
<P>In this updated version we searched the Cochrane Central Register of Controlled Trials (CENTRAL) (March 2015); MEDLINE (1960 to March 2015); and EMBASE (1980 to March 2015). Our search strategies are listed in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>; <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>; and <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>.</P>
<P>We searched the Cochrane Anaesthesia Review Group Specialized Register using the terms: anaesthesia with local or regional or retrobulbar or intraconal or peribulbar or periocular. We then combined these terms with: cataract or intraocular lens or halogenous.</P>
<P>We searched both CENTRAL and MEDLINE using the MeSH terms: anaesthesia, local; and the text terms: retrobulbar anaesthesia or block, peribulbar anaesthesia or block, intraconal or periocular. We then combined these terms with the following MeSH terms: cataract extraction or lens implantation, intraocular; and the text terms: cataract surgery, cataract extraction, senile cataract or age-related cataract or halogenous.</P>
<P>We searched EMBASE using the MeSH terms: regional anaesthesia (exploded, which includes the term retrobulbar anaesthesia), topical anaesthesia (exploded), peribulbar anaesthesia; and the text terms: retrobulbar anaesthesia or block, peribulbar anaesthesia or block, intraconal or periocular. These terms were then combined with the following MeSH terms: cataract extraction (exploded), senile cataract, lens implant; and the text terms: cataract surgery, cataract extraction, senile cataract or age-related cataract or halogenous.</P>
<P>We searched the reference lists of identified trials to find additional trials. We used the Science Citation Index to find studies that cited the identified trials. We contacted the primary investigators of identified trials for information on additional trials.</P>
<P>We did not apply any language restriction.</P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2015-06-11 02:07:53 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Selection of trials</HEADING>
<P>Two authors (MA and FK) independently screened the titles and abstracts identified from the searches. We resolved differences by consulting with the third author (HE).</P>
<P>We obtained full copies of potentially relevant trials. We assessed the full copies according to the 'Criteria for considering studies for this review'. We then assessed trials meeting these criteria for methodological quality. We resolved differences by consulting with the third author (HE).<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Assessment of methodological quality</HEADING>
<P>In our previous version we graded trial quality as: A - low risk of bias; B - moderate risk of bias; C - high risk of bias.</P>
<P>In this updated version of the review we assessed the quality of included RCTs following the Cochrane approach. We used the methods detailed in Chapter Eight of the Cochrane Handbook for Systematic Reviews of Interventions (<LINK REF="REF-Higgins-2009" TYPE="REFERENCE">Higgins 2009</LINK>). We considered the following variables: allocation concealment; masking of participants and primary investigators (eye surgeons); completeness of follow up; and masking of outcome assessment. Masking is accomplished by ensuring that only the anaesthetist or ophthalmologist (who does not determine eligibility and is not responsible for outcome assessment) provides the block according to a randomly generated schedule.</P>
<P>We assessed trial quality as: 'yes' indicating that the study met that quality parameter, 'no' it did not, or 'unclear' indicating that there was insufficient evidence to make a judgement either way. We contacted investigators for variables graded as unclear. Two authors (MA and FK) assessed trial quality independently; a third author (HE) helped to resolve any disagreements.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Data collection</HEADING>
<P>Two authors (MA and FK) independently extracted data into a form developed specifically for the review. We resolved discrepancies by discussion. We extracted data, as far as possible, on the basis of an intention-to-treat analysis. We contacted primary investigators for missing data. Two authors (MA and FK) independently entered all data into Review Manager (<LINK REF="REF-RevMan-5.0" TYPE="REFERENCE">RevMan 5.0</LINK>). We resolved disagreements by discussion that reached a consensus.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Data synthesis</HEADING>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">
<I>Summary statistic</I>s</HEADING>
<P>We calculated mean difference (MD) for continuous variables and relative risk (RR) for dichotomous variables.<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Heterogeneity</HEADING>
<P>We assessed heterogeneity using the I<SUP>2</SUP> statistic. We defined significant heterogeneity as an I<SUP>2</SUP> statistic greater than 50%, P value of less than 0.1. We calculated a pooled summary estimate using a fixed-effect model where there was no significant heterogeneity. Where there was significant heterogeneity, and depending on the number of trials included, we used a random-effects model.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Sensitivity analysis</HEADING>
<P>We planned to perform a sensitivity analysis by including and excluding trials without concealment of allocation. If there were enough trials, we had planned to assess the effects of sedation, age, number of injection sites, and volume of anaesthetic agent used on the outcome measures.</P>
<P>A narrative summary of trial results was presented when the variables were reported in a diverse way or if only one trial reported a variable.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Inclusion and exclusion criteria</HEADING>
<P>We included and excluded studies according to the criteria for considering studies for this review and the methodological quality assessment of the trials, that is: allocation concealment; masking of participants and investigators; completeness of follow up; and masking of outcome assessment.</P>
<OL>
<LI>We included only RCTs.</LI>
<LI>We excluded trials comparing peribulbar or retrobulbar anaesthesia with any others forms of anaesthesia for cataract surgery.</LI>
<LI>We included trials with unclear allocation concealment if the other methodological qualities were adequate.</LI>
<LI>We excluded trials in which cataract surgery was combined with any other ocular surgery.</LI>
</OL>
</SUBSECTION>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2015-06-26 13:36:12 +0100" MODIFIED_BY="Jane Cracknell">
<STUDY_DESCRIPTION MODIFIED="2015-06-26 13:36:12 +0100" MODIFIED_BY="Jane Cracknell">
<P>We identified a total of 871 citations from the database searches, manual searches and citation review (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>). After screening the citations by title and then abstract, we obtained full paper copies for 22 study reports that were potentially eligible for inclusion in the review. Of these, 12 were excluded for the reasons described in the table '<LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>'. We did not identify any ongoing study. Four trials are awaiting assessment because we have not yet obtained full papers (see '<LINK TAG="CHARACTERISTICS_OF_AWAITING_STUDIES" TYPE="SECTION">Characteristics of studies awaiting classification</LINK>'). Six studies met our inclusion criteria. The six studies enrolled 1438 patients. For full details of the six included studies see the table '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>'. All the trials had unclear allocation concealment while three trials had adequate sequence generation. The studies fell broadly into two groups: studies with adequate allocation of concealment (three trials); and those with unclear allocation concealment (three trials).</P>
<SUBSECTION>
<HEADING LEVEL="3">Interventions</HEADING>
<P>All the studies were hospital based. One study used lidocaine alone as anaesthetic agent while the others used a combination of lidocaine and either bupivacaine or mepivacaine and bupivacaine (see
 
'<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>').
 
Sedation was given before injection of the local anaesthetic in two trials (<LINK REF="STD-Ali_x002d_Melkkila-1992" TYPE="STUDY">Ali-Melkkila 1992;</LINK> <LINK REF="STD-Weiss-1989" TYPE="STUDY">Weiss 1989</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Outcome measures</HEADING>
<P>The pain score was assessed in three trials (<LINK REF="STD-Athanikar-1991" TYPE="STUDY">Athanikar 1991</LINK>; <LINK REF="STD-Weiss-1989" TYPE="STUDY">Weiss 1989</LINK>; <LINK REF="STD-Wong-1993" TYPE="STUDY">Wong 1993</LINK>). This pain score assesses the level of pain as reported by the participant during cataract surgery. <LINK REF="STD-Athanikar-1991" TYPE="STUDY">Athanikar 1991</LINK> graded globe anaesthesia on a scale of 0 to +++, where 0 was inadequate anaesthesia for continuing with surgery; + was not ideal but adequate to continue; ++ was not ideal but more than adequate to continue; and +++ was total anaesthesia. <LINK REF="STD-Weiss-1989" TYPE="STUDY">Weiss 1989</LINK> rated globe anaesthesia on a four-point scale, where 4 meant total anaesthesia; 3 meant more than adequate but not quite total; 2 meant not ideal but just adequate to proceed; and 1 meant inadequate to proceed. <LINK REF="STD-Wong-1993" TYPE="STUDY">Wong 1993</LINK> graded globe anaesthesia as: optimal; not optimal but able to proceed; and not optimal and unable to proceed.</P>
<P>Globe akinesia was assessed in five trials (<LINK REF="STD-Ali_x002d_Melkkila-1992" TYPE="STUDY">Ali-Melkkila 1992</LINK>; <LINK REF="STD-Ali_x002d_Melkkila-1993" TYPE="STUDY">Ali-Melkkila 1993</LINK>; <LINK REF="STD-Athanikar-1991" TYPE="STUDY">Athanikar 1991</LINK>; <LINK REF="STD-Weiss-1989" TYPE="STUDY">Weiss 1989</LINK>; <LINK REF="STD-Wong-1993" TYPE="STUDY">Wong 1993</LINK>). Grade 'A' block was defined as a total block with no movement of the eye ball; grade 'B' block was defined as movement of the eye ball that was not severe enough to prevent the surgery; grade 'C' block was defined as movement of the eye ball with a need for additional injections. Counts for Grade 'A' block (complete akinesia) were used for summary statistics for globe akinesia. This is because <LINK REF="REF-RevMan-5.0" TYPE="REFERENCE">RevMan 5.0</LINK> does not support ordinal variables.</P>
<P>Need for supplemental injection was assessed in four trials (<LINK REF="STD-Ali_x002d_Melkkila-1992" TYPE="STUDY">Ali-Melkkila 1992</LINK>; <LINK REF="STD-Ali_x002d_Melkkila-1993" TYPE="STUDY">Ali-Melkkila 1993</LINK>; <LINK REF="STD-Weiss-1989" TYPE="STUDY">Weiss 1989</LINK>; <LINK REF="STD-Wong-1993" TYPE="STUDY">Wong 1993</LINK>).</P>
<P>Complications resulting from the two anaesthetic interventions were reported in all the studies except <LINK REF="STD-Weiss-1989" TYPE="STUDY">Weiss 1989</LINK>.</P>
<P>Patient acceptability of the two interventions was reported in the <LINK REF="STD-Ali_x002d_Melkkila-1992" TYPE="STUDY">Ali-Melkkila 1992</LINK> and <LINK REF="STD-Wong-1993" TYPE="STUDY">Wong 1993</LINK> trials. <LINK REF="STD-Ali_x002d_Melkkila-1992" TYPE="STUDY">Ali-Melkkila 1992</LINK> assessed a patient's acceptability by asking whether the participant preferred general anaesthesia to local anaesthesia; while <LINK REF="STD-Wong-1993" TYPE="STUDY">Wong 1993</LINK> asked whether the participant would have the same block again.<BR/>
</P>
</SUBSECTION>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2015-05-01 21:42:49 +0100" MODIFIED_BY="[Empty name]">
<P>(see '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>'; <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>).<BR/>
</P>
<P>
<LINK REF="STD-Ali_x002d_Melkkila-1992" TYPE="STUDY">Ali-Melkkila 1992</LINK> randomized 300 patients to receive either periocular or retrobulbar anaesthesia. The concealment of allocation was not clear in the report. However, masking of participants and primary investigators, completeness of follow up and masking of outcome assessment were adequate.</P>
<P>
<LINK REF="STD-Ali_x002d_Melkkila-1993" TYPE="STUDY">Ali-Melkkila 1993</LINK> randomized 450 patients to receive either periocular or retrobulbar anaesthesia. The concealment of allocation was unclear in the report. The periocular group was further divided into two groups (P1 and P2). The masking of participants and primary investigators and masking of outcome assessment were adequate.</P>
<P>
<LINK REF="STD-Athanikar-1991" TYPE="STUDY">Athanikar 1991</LINK> randomized 142 patients to receive either one-point low volume peribulbar anaesthesia or retrobulbar anaesthesia using a randomization chart. Separate individuals carried out the administration and the assessment. The masking of outcome assessment was adequate.</P>
<P>
<LINK REF="STD-Feibel-1993" TYPE="STUDY">Feibel 1993</LINK> randomized 317 patients to receive either peribulbar or retrobulbar anaesthesia by the use of a coin toss. The masking of participants and primary investigators and masking of outcome assessment were adequate. The completeness of follow up was adequate.</P>
<P>
<LINK REF="STD-Weiss-1989" TYPE="STUDY">Weiss 1989</LINK> randomized 79 patients to receive either peribulbar or retrobulbar anaesthesia. The method of allocation was unclear. Masking of participants and primary investigators, completeness of follow up and masking of outcome assessment were adequate.</P>
<P>
<LINK REF="STD-Wong-1993" TYPE="STUDY">Wong 1993</LINK> randomized 150 patients to receive either retrobulbar, peribulbar or modified retrobulbar anaesthesia. The allocation concealment was adequate. Masking of participants and primary investigators and masking of outcome assessment were adequate. The modified RB consisted of a single needle insertion superomedially through the upper lid at a point midway between the medial canthus and the supraorbital notch and the needle then advanced slowly in the sagittal plane to a depth of 32 to 33 mm.<BR/>
</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2011-03-11 10:18:44 +0000" MODIFIED_BY="[Empty name]">
<P>A total of 1438 participants were included in the review. There was significant heterogeneity in the grading system used for outcome measures amongst the included trials. Data were pooled where the grading system was similar. The third author was contacted three times to resolve disagreements on whether to include or exclude a trial. We contacted five authors for further information. There was no response from three whilst the letters were returned from two addresses stating 'No longer at this address' (see Summary of findings table 1).</P>
<SUBSECTION>
<HEADING LEVEL="3">Pain score</HEADING>
<P>(see <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>)</P>
<P>Pain control during surgery (globe anaesthesia) was no different between retrobulbar anaesthesia and peribulbar anaesthesia.</P>
<P>Two trials involving 221 participants reported on pain scores (<LINK REF="STD-Athanikar-1991" TYPE="STUDY">Athanikar 1991</LINK>; <LINK REF="STD-Weiss-1989" TYPE="STUDY">Weiss 1989</LINK>) (see <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>). The pooled summary effect was a weighted mean difference (WMD) of - 0.03 (95% CI -0.17 to 0.11). There was no significant heterogeneity (Chi<SUP>2</SUP> = 0.63, P = 0.43). In <LINK REF="STD-Wong-1993" TYPE="STUDY">Wong 1993</LINK> the rates of optimal anaesthesia were: RB 93/100 (0.93) and PB 49/50 (0.98).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Globe akinesia</HEADING>
<P>(see <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>)</P>
<P>There was no difference in the rate of complete akinesia with the two types of anaesthesia. Five trials reported akinesia as an outcome measure. One trial (<LINK REF="STD-Weiss-1989" TYPE="STUDY">Weiss 1989</LINK>) assessed akinesia as a mean score and the mean scores were: peribulbar anaesthesia 2.96 (standard deviation (SD)1.4); retrobulbar anaesthesia 3.76 (SD 0.43). In this trial RB gave better akinesia than PB. Four trials (<LINK REF="STD-Athanikar-1991" TYPE="STUDY">Athanikar 1991</LINK>; <LINK REF="STD-Ali_x002d_Melkkila-1992" TYPE="STUDY">Ali-Melkkila 1992</LINK>; <LINK REF="STD-Ali_x002d_Melkkila-1993" TYPE="STUDY">Ali-Melkkila 1993</LINK>; <LINK REF="STD-Wong-1993" TYPE="STUDY">Wong 1993</LINK>) involving a total of 1042 participants were analysed for presence of complete akinesia. <LINK REF="STD-Athanikar-1991" TYPE="STUDY">Athanikar 1991</LINK> was not included in the pooled summary effect because all the participants had complete akinesia for the two interventions. The pooled summary effect for grade 'A' blocks was RR 0.96 (95% CI 0.82 to 1.13) using a random-effects model. The test for heterogeneity was significant (P = 0.01, I<SUP>2</SUP> = 77.9%). The overall effect was not significant (P = 0.62). A sensitivity analysis was not done because of the small number of included trials.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Need for supplemental injection</HEADING>
<P>(see <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>)</P>
<P>Four trials ( <LINK REF="STD-Ali_x002d_Melkkila-1992" TYPE="STUDY">Ali-Melkkila 1992</LINK>; <LINK REF="STD-Ali_x002d_Melkkila-1993" TYPE="STUDY">Ali-Melkkila 1993</LINK>; <LINK REF="STD-Weiss-1989" TYPE="STUDY">Weiss 1989</LINK>; <LINK REF="STD-Wong-1993" TYPE="STUDY">Wong 1993</LINK>) reported supplemental blocks amongst a total of 1029 participants. The direction of effect favoured peribulbar anaesthesia in <LINK REF="STD-Wong-1993" TYPE="STUDY">Wong 1993</LINK> whilst it favoured retrobulbar anaesthesia in the other three trials. The pooled summary statistic was RR 1.54 (96% CI 0.91 to 2.60) using a random-effects model. There was significant heterogeneity (Chi<SUP>2</SUP> = 7.94, P = 0.05, 1<SUP>2</SUP> = 62.2%). The summary RR was not significant (P = 0.11) (see <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Complications</HEADING>
<P>(see <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>)</P>
<SUBSECTION>
<HEADING LEVEL="4">Local</HEADING>
<P>Retrobulbar haemorrhage was reported in 1/71 (0.3%) participants in the retrobulbar group, in one trial (<LINK REF="STD-Athanikar-1991" TYPE="STUDY">Athanikar 1991</LINK>). There was no report of retrobulbar haemorrhage in the peribulbar group.</P>
<P>Conjunctival chemosis was documented in four trials (<LINK REF="STD-Athanikar-1991" TYPE="STUDY">Athanikar 1991</LINK>; <LINK REF="STD-Ali_x002d_Melkkila-1992" TYPE="STUDY">Ali-Melkkila 1992</LINK>; <LINK REF="STD-Ali_x002d_Melkkila-1993" TYPE="STUDY">Ali-Melkkila 1993</LINK>; <LINK REF="STD-Wong-1993" TYPE="STUDY">Wong 1993</LINK>). The risk for conjunctival chemosis was 17.4% (98/563) in the PBs and 7.1% (34/479) in the RBs. The mean volume of anaesthetic solution used for the blocks was 8.3 ml and 4.7 ml, respectively. The RR (fixed-effect model) was 2.11 (95% CI 1.46 to 3.05; P &lt; 0.00001). There was no significant heterogeneity (1<SUP>2</SUP> = 31.9%) (see <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>). The risk for conjunctival chemosis was more with PB than RB. This may be due to more anterior delivery of anaesthetic agent in the orbit and the generally larger volume of anaesthetic injected.<BR/>
</P>
<P>One trial (<LINK REF="STD-Ali_x002d_Melkkila-1993" TYPE="STUDY">Ali-Melkkila 1993</LINK>) reported lid haematoma as a local complication. The risk for lid haematoma was 2.7% (8/300) in the PBs and 7.3% (11/150) in the RBs. The rate was much higher in RB than PB (P = 0.03) (see <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>).</P>
<P>Persistent ptosis (measured as the amount of decrease in the lid fissure drop at 90 days after surgery, where it was equal to or greater than 2 mm) occurred in nine (1.1%) of the participants in the peribulbar group and nine (1.3%) participants in the retrobulbar group. There was no difference in the risk of having ptosis (RR 1.06, 95% CI 0.43 to 2.60; P = 0.9). Only one study reported on this outcome (<LINK REF="STD-Feibel-1993" TYPE="STUDY">Feibel 1993</LINK>).<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Systemic</HEADING>
<P>No major systemic complications were reported in any of the trials.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Effect of sedation</HEADING>
<P>Pain control and globe akinesia were no different between the participants that received sedation and those that did not. In <LINK REF="STD-Ali_x002d_Melkkila-1992" TYPE="STUDY">Ali-Melkkila 1992</LINK> each patient received alfentanil 15 minutes before anaesthesia whilst in <LINK REF="STD-Weiss-1989" TYPE="STUDY">Weiss 1989</LINK> 0.5 to 1mg of intravenous idazolam was administered before anaesthesia.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Acceptability of block</HEADING>
<P>(see <LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>)</P>
<P>There was no difference in the number of participants who reported the block to be acceptable between the two anaesthetic techniques (see <LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>). <LINK REF="STD-Ali_x002d_Melkkila-1992" TYPE="STUDY">Ali-Melkkila 1992</LINK> and <LINK REF="STD-Wong-1993" TYPE="STUDY">Wong 1993</LINK> reported acceptability of the block for the two interventions. In the peribulbar group 98.5% (345/350) accepted the block whilst in the retrobulbar group 96.8% (242/250) accepted the block. The RR (fixed-effect model) was 1.01 (95% CI 0.98 to 1.03). The test for heterogeneity showed no significant heterogeneity (Chi<SUP>2</SUP> = 1.55, P = 0.21, 1<SUP>2</SUP>= 35.3%).</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2015-05-01 21:42:49 +0100" MODIFIED_BY="[Empty name]">
<P>Historically, retrobulbar anaesthesia has been associated with good anaesthesia and eye ball paralysis but severe local and systemic complications. This led to the development of peribulbar anaesthesia and modified techniques that were thought to be equally effective in producing both akinesia and anaesthesia with less severe globe or life-threatening complications. The objective of this review was to provide evidence for this assertion. Earlier non-systematic reviews have not provided convincing evidence on the relative efficacy of retrobulbar and peribulbar anaesthesia for cataract surgery (<LINK REF="REF-Friedman-2001a" TYPE="REFERENCE">Friedman 2001a</LINK>). <LINK REF="REF-Friedman-2001b" TYPE="REFERENCE">Friedman 2001b</LINK> assessed study quality and eligibility for inclusion but three studies with high risk of bias were included in their review (<LINK REF="STD-Murdoch-1990" TYPE="STUDY">Murdoch 1990</LINK>; <LINK REF="STD-Saunders-1993" TYPE="STUDY">Saunders 1993</LINK>; <LINK REF="STD-Whitsett-1990" TYPE="STUDY">Whitsett 1990</LINK>).</P>
<P>In the present review, we did not find any difference in pain control (globe anaesthesia) between PB and RB (WMD - 0.03, 95% CI -0.17 to 0.11). For globe akinesia grade 'A' block, that is a total block with no movement of the eye ball, the rates were similar with the two techniques (RR 1.04, 95% CI 0.89 to 1.22); see <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>. This is similar to the findings in the Friedman review where they found that there was no difference in rate of complete akinesia or the ability of PB and RB to provide pain control during cataract surgery (<LINK REF="REF-Friedman-2001a" TYPE="REFERENCE">Friedman 2001a</LINK>).</P>
<P>In the present review planned preanaesthesia sedation did not affect the pain score or akinesia; in the two trials in which it was used. The need for additional injection was higher with PB than for RB (RR 1.54, 95% CI 0.91 to 2.60). This trend was consistent in three of the included trials. This difference was not, however, statistically significant (see Summary of findings table 1). <LINK REF="REF-Friedman-2001a" TYPE="REFERENCE">Friedman 2001a</LINK> did not report on this outcome in their review. Evidence could not be provided for retrobulbar haemorrhage because it was reported in only one patient, in the <LINK REF="STD-Athanikar-1991" TYPE="STUDY">Athanikar 1991</LINK> trial. Persistent ptosis rate was similar between techniques in <LINK REF="STD-Feibel-1993" TYPE="STUDY">Feibel 1993</LINK>. There is some evidence that conjunctival chemosis occurs more often after PB than RB; this was statistically significant (P &lt; 0.00001). No major systemic complication were reported in the included trials (see <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>).</P>
<P>The strength of the evidence in this review is low for pain score, akinesia and need for additional injection. This is due to the poor methodological quality of the included studies (see '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>' and risk of bias tables; <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>; <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>). The method of concealment of allocation was unclear in three of the six included studies (we have contacted the primary investigators of these three studies and are waiting for them to clarify the method of concealment). Secondly, the total number of participants included in the review was small considering the large number of cataract surgery procedures carried out daily, worldwide. This is compounded by our inability to pool results due to the differences in the methods of reporting the outcome measures. Data could only be pooled for akinesia, for four of the included studies (see <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>). In the <LINK REF="REF-Friedman-2001b" TYPE="REFERENCE">Friedman 2001b</LINK> review the included studies were scored for representativeness (37%), bias and confounding (48%), description of therapy (35%), statistical quality and interpretation (39%), study outcome and follow up (58%).</P>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE MODIFIED="2008-04-05 05:14:58 +0100" MODIFIED_BY="[Empty name]">
<P>There is no evidence that peribulbar anaesthesia gives better akinesia and anaesthesia than retrobulbar anaesthesia for cataract surgery. We did not, however, assess pain during injection. There is some evidence that peribulbar anaesthesia causes more conjunctival chemosis than with retrobulbar anaesthesia. The rates of severe local and systemic complications are very rare. There is thus no evidence of a difference in the efficacy and safety profiles for PB and RB for anaesthetists, surgeons or patients.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2008-04-05 05:29:43 +0100" MODIFIED_BY="[Empty name]">
<P>There is a need to pay good attention to methodology in research on local anaesthesia for cataract surgery. Outcome measures need to be assessed quantitatively rather than with qualitative measures, for example using visual analogue scores for pain and millimetre movement of each rectus muscle for akinesia.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2008-04-05 05:30:09 +0100" MODIFIED_BY="[Empty name]">
<P>We would like to thank Professor Andrew Smith, Dr Maurizio Solca, Dr Richard Wormald and Professor NL Pace for their help and editorial advice during the preparation of this review. We would also like to thank the Cochrane Eye and Vision Group for their editorial input and the Cochrane Anaesthesia Review Group for providing materials.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2011-03-11 10:28:37 +0000" MODIFIED_BY="[Empty name]">
<P>None known</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2011-03-11 10:28:35 +0000" MODIFIED_BY="[Empty name]">
<P>Conceiving the review: Mahmoud Alhassan (MA)</P>
<P>Co-ordinating the review: MA</P>
<P>Undertaking manual searches:MA, Fatima Kyar (FK), Henry Ejere (HE)</P>
<P>Screening search results: MA, FK, HE</P>
<P>Organizing retrieval of papers: MA, FK, HE</P>
<P>Screening retrieved papers against inclusion criteria: MA, FK, HE</P>
<P>Appraising quality of papers: MA, FK, HE</P>
<P>Abstracting data from papers: MA, FK</P>
<P>Writing to authors of papers for additional information: MA</P>
<P>Providing additional data about papers: </P>
<P>Obtaining and screening data on unpublished studies: </P>
<P>Data management for the review: MA, FK, HE</P>
<P>Entering data into Review Manager (<LINK REF="REF-RevMan-5.0" TYPE="REFERENCE">RevMan 5.0</LINK>): MA, FK, HE</P>
<P>RevMan statistical data: MA, FK</P>
<P>Other statistical analysis not using RevMan:</P>
<P>Double entry of data: (data entered by person one: MA; data entered by person two: FK)</P>
<P>Interpretation of data: MA, FK, HE</P>
<P>Statistical inferences: MA, FK, HE</P>
<P>Writing the review: MA, FK, HE</P>
<P>Securing funding for the review: MA, FK, HE</P>
<P>Performing previous work that was the foundation of the present study:</P>
<P>Guarantor for the review (one author): MA</P>
<P>Person responsible for reading and checking review before submission: MA</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2015-06-11 11:00:47 +0100" MODIFIED_BY="Jane Cracknell">
<STUDIES MODIFIED="2011-03-11 10:38:18 +0000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell">
<STUDY DATA_SOURCE="PUB" ID="STD-Ali_x002d_Melkkila-1992" MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell" NAME="Ali-Melkkila 1992" YEAR="1992">
<REFERENCE MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ali Melkkila TM, Virkkila M, Jyrkkio H</AU>
<TI>Regional anesthesia for cataract surgery: comparison of retrobulbar and peribulbar techniques</TI>
<SO>Indian Journal of Ophthalmology</SO>
<YR>1992</YR>
<VL>39</VL>
<PG>48-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1515389"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ali_x002d_Melkkila-1993" MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell" NAME="Ali-Melkkila 1993" YEAR="1993">
<REFERENCE MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ali-Melkkila T, Markku V, Keino K, Palve H</AU>
<TI>Regional anaesthesia for cataract surgery: comparison of three techniques [see comments]</TI>
<SO>British Journal of Ophthalmology</SO>
<YR>1993</YR>
<VL>77</VL>
<NO>12</NO>
<PG>771-3</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="8110669"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Athanikar-1991" NAME="Athanikar 1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Athanikar NS, Agrawal VB</AU>
<TI>One point low volume peribulbar anaesthesia versus retrobulbar anaesthesia a prospective clinical trial</TI>
<SO>Indian Journal of Ophthalmology</SO>
<YR>1991</YR>
<VL>39</VL>
<NO>2</NO>
<PG>48-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1916978"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Feibel-1993" MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell" NAME="Feibel 1993" YEAR="1993">
<REFERENCE MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Feibel RM, Custer PL, Gordon MO</AU>
<TI>Postcataract ptosis. A randomized, double-masked comparison of peribulbar and retrobulbar anesthesia</TI>
<SO>Ophthalmology</SO>
<YR>1993</YR>
<VL>100</VL>
<PG>660-5</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="8493007"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weiss-1989" MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell" NAME="Weiss 1989" YEAR="1989">
<REFERENCE MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Weiss JL, Deichman CB</AU>
<TI>A comparison of retrobulbar and periocular anesthesia for cataract surgery</TI>
<SO>Archives of Ophthalmology</SO>
<YR>1989</YR>
<VL>107</VL>
<PG>96-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="2910293"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wong-1993" MODIFIED="2008-04-05 05:58:17 +0100" MODIFIED_BY="[Empty name]" NAME="Wong 1993" YEAR="19933">
<REFERENCE MODIFIED="2008-04-05 05:58:17 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Wong HW, Koehrer E, Sutton HF</AU>
<TI>A modified retrobulbar block for eye surgery</TI>
<SO>Canadian Journal of Anaesthesia (Journal Canadien d'Anesthésie)</SO>
<YR>1993</YR>
<VL>40</VL>
<NO>6</NO>
<PG>547-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2011-03-11 10:37:39 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Asensio-1994" NAME="Asensio 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Asensio SVM, Sanchez BJ, Martin S, Merchan L</AU>
<TI>Comparison of retrobulbar and peribulbar anaesthesia for cataract surgery</TI>
<SO>Archivos de la Sociedad Española de Oftalmología</SO>
<YR>1994</YR>
<VL>66</VL>
<PG>171-4</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="00168753"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barker-1989" MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell" NAME="Barker 1989" YEAR="1989">
<REFERENCE MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barker J P, Robinson PN, Vafidis GC, Hart GR, Hall GM</AU>
<TI>Local anaesthesia for cataract surgery</TI>
<SO>Lancet</SO>
<YR>1989</YR>
<VL>1</VL>
<PG>393</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="2563555"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Edge-1995" MODIFIED="2008-04-05 05:59:37 +0100" MODIFIED_BY="[Empty name]" NAME="Edge 1995" YEAR="1995">
<REFERENCE MODIFIED="2008-04-05 05:59:37 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Edge KR, McClarty CP, Krige SJ, Rantalainan RR</AU>
<TI>Comparison of an extraconal block with a retrobulbar-facial block combination for ocular surgery</TI>
<SO>South African Journal of Surgery</SO>
<YR>1995</YR>
<VL>33</VL>
<NO>3</NO>
<PG>117-20</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="8607053"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hessemer-1994" NAME="Hessemer 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hessemer V</AU>
<TI>Peribulbar anesthesia versus retrobulbar anesthesia with facial block. Techniques local anesthetics and additives, akinesia and sensory blockade, complications</TI>
<SO>Klinische Monatsblätter für Augenheilkunde</SO>
<YR>1994</YR>
<VL>204</VL>
<PG>75-89</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="8170098"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jacobi-2000" NAME="Jacobi 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jacobi PC, Dietlein TS, Jacobi FK</AU>
<TI>A comparative study of topical versus retrobulbar anesthesia in complicated cataract surgery</TI>
<SO>Archives of Ophthalmology</SO>
<YR>2000</YR>
<VL>118</VL>
<NO>8</NO>
<PG>1037-43</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="10982042"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lavinsky-2000" MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell" NAME="Lavinsky 2000" YEAR="2000">
<REFERENCE MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lavinsky J, Gus PI, Ehlers JA, Roehe D, Nora DB</AU>
<TI>Visual-evoked potentials: assessment of retrobulbar and peribulbar anesthesia</TI>
<SO>Journal of Cataract and Refractive Surgery</SO>
<YR>2000</YR>
<VL>26</VL>
<PG>1529-32</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="11033402"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Murdoch-1990" MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell" NAME="Murdoch 1990" YEAR="1990">
<REFERENCE MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Murdoch I</AU>
<TI>Peribulbar versus retrobulbar anaesthesia</TI>
<SO>Eye</SO>
<YR>1990</YR>
<VL>4</VL>
<PG>445-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="2209907"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ramsay-2001" MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell" NAME="Ramsay 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ramsay AS, Ray Chaudhuri N, Dayan M, Walshaw D</AU>
<TI>Quantification of relative afferent pupillary defects induced by posterior sub-Tenon's, peribulbar, and retrobulbar anaesthetics</TI>
<SO>British Journal of Ophthalmology</SO>
<YR>2001</YR>
<VL>85</VL>
<PG>1445-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="11734518"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ropo-1992" MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell" NAME="Ropo 1992" YEAR="1992">
<REFERENCE MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ropo A, Ruusuvaara P Setala K</AU>
<TI>Visual evoked potentials after retrobulbar or periocular anaesthesia</TI>
<SO>British Journal of Ophthalmology</SO>
<YR>1992</YR>
<VL>76</VL>
<PG>541-4</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1420059"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sanford-1998" MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell" NAME="Sanford 1998" YEAR="1998">
<REFERENCE MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sanford D K, Minoso y de Cal OE, Belyea DA</AU>
<TI>Response of intraocular pressure to retrobulbar and peribulbar anesthesia</TI>
<SO>Ophthalmic Surgery and Lasers</SO>
<YR>1998</YR>
<VL>29</VL>
<PG>815-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="9793946"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Saunders-1993" MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell" NAME="Saunders 1993" YEAR="1993">
<REFERENCE MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Saunders DC, Sturgess DA, Pemberton CJ, Morgan LH, Bourne A</AU>
<TI>Peribulbar and retrobulbar anesthesia with prilocaine: a comparison of two methods of local ocular anesthesia</TI>
<SO>Ophthalmic Surgery</SO>
<YR>1993</YR>
<VL>24</VL>
<NO>12</NO>
<PG>842-5</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="8115101"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Whitsett-1990" MODIFIED="2011-03-11 10:37:39 +0000" MODIFIED_BY="[Empty name]" NAME="Whitsett 1990" YEAR="1990">
<REFERENCE MODIFIED="2011-03-11 10:37:39 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Whitsett J C, Balyeat HD, McClure B</AU>
<TI>Comparison of one-injection-site peribulbar anesthesia and retrobulbar anesthesia</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>1990</YR>
<VL>16</VL>
<PG>527-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="2256971"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2011-03-11 10:38:18 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Agrawal-1993" MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell" NAME="Agrawal 1993" YEAR="1993">
<REFERENCE MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Agrawal K, Saxena RC, Nath R. Saxena S</AU>
<TI>Local anesthesia by peribulbar block for cataract extraction in an eye relief camp</TI>
<SO>Online Journal of Current Clinical Trials</SO>
<YR>1993</YR>
<VL>19</VL>
<PG>Doc No 40</PG>
<IDENTIFIERS MODIFIED="2010-12-09 17:12:51 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2010-12-09 17:12:51 +0000" MODIFIED_BY="Jane Cracknell" TYPE="MEDLINE" VALUE="8306001"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2008-03-23 05:57:32 +0000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-1996" MODIFIED="2008-03-23 05:46:39 +0000" MODIFIED_BY="[Empty name]" NAME="Li 1996" YEAR="1996">
<REFERENCE MODIFIED="2008-03-23 05:46:36 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li H, Li XE</AU>
<TI>Comparison of retrobulbar and periocular anesthesia for cataract surgery</TI>
<SO>Journal of Henyang Medical College</SO>
<YR>1996</YR>
<VL>24</VL>
<PG>49-51</PG>
<IDENTIFIERS MODIFIED="2008-03-23 05:46:36 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Meyer-1992" MODIFIED="2011-03-11 10:38:18 +0000" MODIFIED_BY="[Empty name]" NAME="Meyer 1992" YEAR="1992">
<REFERENCE MODIFIED="2011-03-11 10:38:18 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Meyer D, Hamilton RC, Loken RG, Bimbel HV</AU>
<TI>Effect of combined peribulbar and retrobulbar injection of large volume of anesthetic agents on the intraocular pressure</TI>
<SO>Canadian Journal of Ophthalmology</SO>
<YR>1992</YR>
<VL>27</VL>
<PG>230-2</PG>
<IDENTIFIERS MODIFIED="2008-03-23 05:56:58 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-03-23 05:56:58 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="1393807"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2008-03-23 05:54:00 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-03-23 05:54:00 +0000" MODIFIED_BY="[Empty name]" OTHERTYPE="Medline" TYPE="OTHER" VALUE="1393807"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sanders-1997" MODIFIED="2010-12-09 17:15:28 +0000" MODIFIED_BY="Jane Cracknell" NAME="Sanders 1997" YEAR="1997">
<REFERENCE MODIFIED="2010-12-09 17:15:28 +0000" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sanders R, Ahmed S, Craig EW, Young JD</AU>
<TI>Comparison of catecholmine and pressor effects in peribulbar and retrobulbar anaesthesia in cataract surgery</TI>
<SO>Eye</SO>
<YR>1997</YR>
<VL>11</VL>
<PG>644-8</PG>
<IDENTIFIERS MODIFIED="2010-12-09 17:15:28 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2010-12-09 17:15:28 +0000" MODIFIED_BY="Jane Cracknell" TYPE="MEDLINE" VALUE="9474311"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2008-03-23 06:07:15 +0000" MODIFIED_BY="[Empty name]"/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2015-06-11 11:00:47 +0100" MODIFIED_BY="Jane Cracknell">
<ADDITIONAL_REFERENCES MODIFIED="2011-03-11 10:40:59 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Davis-1986" MODIFIED="2008-06-02 22:42:35 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Davis 1986" TYPE="JOURNAL_ARTICLE">
<AU>Davis DB 2nd, Mandel MR</AU>
<TI>Posterior peribulbar anaesthesia: an alternative to retrobulbar anaesthesia</TI>
<SO>Journal of Cataract and Refractive Surgery</SO>
<YR>1986</YR>
<VL>12</VL>
<PG>182</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Davis-1989" MODIFIED="2008-06-02 22:42:35 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Davis 1989" TYPE="JOURNAL_ARTICLE">
<AU>Davis DB 2nd, Mandel MR</AU>
<TI>Posterior peribulbar anaesthesia: an alternative to retrobulbar anaesthesia</TI>
<SO>Indian Journal of Ophthalmology</SO>
<YR>1989</YR>
<VL>37</VL>
<PG>59-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Davis-1994" MODIFIED="2011-03-11 10:39:10 +0000" MODIFIED_BY="[Empty name]" NAME="Davis 1994" TYPE="JOURNAL_ARTICLE">
<AU>Davis DB 2nd, Mandel MR</AU>
<TI>Efficacy and complication rate of 16,224 consecutive peribulbar blocks. A prospective multicentre study</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>1994</YR>
<VL>20</VL>
<NO>6</NO>
<PG>263</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Foster-1999" MODIFIED="2008-06-02 22:42:35 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Foster 1999" TYPE="JOURNAL_ARTICLE">
<AU>Foster A</AU>
<TI>Cataract -- a global perspective: output, outcome and outlay</TI>
<SO>Eye</SO>
<YR>1999</YR>
<VL>13</VL>
<PG>449-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Friedman-2001a" MODIFIED="2008-06-02 22:42:35 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Friedman 2001a" TYPE="JOURNAL_ARTICLE">
<AU>Friedman DS, Bass EB, Lubomski LH, Fleisher LA, Kempen JH, Magaziner J, et al</AU>
<TI>Synthesis of the literature on the effectiveness of regional anesthesia for cataract surgery</TI>
<SO>Ophthalmology</SO>
<YR>2001</YR>
<VL>108</VL>
<NO>3</NO>
<PG>530-41</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="11237906"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Friedman-2001b" MODIFIED="2008-06-02 22:42:35 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Friedman 2001b" TYPE="JOURNAL_ARTICLE">
<AU>Friedman SD, Bass EB, Lubomski LH, Flesher LA, Kempen JH, et al</AU>
<TI>The methodological quality of clinical trials on regional anesthesia for cataract surgery</TI>
<SO>Opthalmology</SO>
<YR>2001</YR>
<VL>108</VL>
<NO>3</NO>
<PG>530-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fry-1990" MODIFIED="2008-06-02 22:42:35 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Fry 1990" TYPE="JOURNAL_ARTICLE">
<AU>Fry RA, Henderson J</AU>
<TI>Local anaesthesia for eye surgery: the peribulbar technique</TI>
<SO>Anaesthesia</SO>
<YR>1990</YR>
<VL>45</VL>
<PG>14-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hamilton-1988" MODIFIED="2011-03-11 10:39:55 +0000" MODIFIED_BY="[Empty name]" NAME="Hamilton 1988" TYPE="JOURNAL_ARTICLE">
<AU>Hamilton RC, Gimble HV, Strunin L</AU>
<TI>Regional anaesthesia for 12,000 cataract extractions and lens implant procedures</TI>
<SO>Canadian Journal of Anaesthesia</SO>
<YR>1988</YR>
<VL>35</VL>
<PG>615-25</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hansen-1998" MODIFIED="2008-06-02 22:42:35 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Hansen 1998" TYPE="JOURNAL_ARTICLE">
<AU>Hansen TE</AU>
<TI>Current trend in cataract surgery in Denmark; 1998 survey</TI>
<SO>Acta Ophthalmologica Scandinavica</SO>
<YR>1999</YR>
<VL>77</VL>
<PG>685-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2009" MODIFIED="2011-03-11 10:40:23 +0000" MODIFIED_BY="[Empty name]" NAME="Higgins 2009" TYPE="OTHER">
<TI>Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]</TI>
<TO>
 
</TO>
<SO>The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Leaming-1999" MODIFIED="2008-06-02 22:42:35 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Leaming 1999" TYPE="JOURNAL_ARTICLE">
<AU>Leaming DV</AU>
<TI>Practice styles and preferences of ASCRS members - 1998 survey</TI>
<SO>Journal of Cataract and Refractive Surgery</SO>
<YR>1999</YR>
<VL>25</VL>
<PG>851-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-5.0" MODIFIED="2008-06-02 22:42:35 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="RevMan 5.0" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan). Version 5.0</TI>
<YR>2007</YR>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Springs-2001" MODIFIED="2011-03-11 10:40:59 +0000" MODIFIED_BY="[Empty name]" NAME="Springs 2001" TYPE="JOURNAL_ARTICLE">
<AU>Springs CL, Broocker G</AU>
<TI>Injectional Orbital Anesthesia for Cataract Surgery</TI>
<SO>Survey of Ophthalmology</SO>
<YR>2001</YR>
<VL>46</VL>
<PG>181-4</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2015-06-11 11:00:47 +0100" MODIFIED_BY="Jane Cracknell">
<REFERENCE ID="REF-Alhassan-2008" MODIFIED="2015-06-11 11:00:47 +0100" MODIFIED_BY="Jane Cracknell" NAME="Alhassan 2008" TYPE="COCHRANE_REVIEW">
<AU>Alhassan MB, Kyari F, Ejere HOD</AU>
<TI>Peribulbar versus retrobulbar anaesthesia for cataract surgery</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2008</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2015-06-11 11:00:28 +0100" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2015-06-11 11:00:26 +0100" MODIFIED_BY="Jane Cracknell" TYPE="DOI" VALUE="10.1002/14651858.CD004083.pub2"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2011-03-11 10:34:05 +0000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2011-03-11 10:34:05 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2011-03-11 10:28:58 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ali_x002d_Melkkila-1992">
<CHAR_METHODS MODIFIED="2011-03-11 10:28:58 +0000" MODIFIED_BY="[Empty name]">
<P>RCT. Allocation concealment not clear; masking of participants and primary investigators, and masking of outcome measure assessment were not reported.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-04-05 05:35:30 +0100" MODIFIED_BY="[Empty name]">
<P>In Finland, 300 patients undergoing ambulatory elective cataract extraction and intraocular lens implantation. Mean age of participants 68 years.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-04-05 05:37:24 +0100" MODIFIED_BY="[Empty name]">
<P>Periocular anaesthesia using 5 cc of anaesthetic agent injected 1 cm medial to the lateral canthus with a 25 mm needle (142) versus retrobulbar anaesthesia using 4 ml of anaesthetic agent injected into the muscle cone through the inferolateral lower lid with 30 mm needle. Premedication with alfentanil 15 minutes before anaesthesia. All blocks were given with a 50:50 mixture of 0.5% bupivacaine and 2% lidocaine with 1:100000 adrenaline and 150 IU hyaluronidase. Mechanical orbital compression applied for 15 minutes.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-04-05 05:35:01 +0100" MODIFIED_BY="[Empty name]">
<P>Globe akinesia, supplemental block, complications.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-02-13 03:48:27 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ali_x002d_Melkkila-1993">
<CHAR_METHODS MODIFIED="2011-02-13 03:48:27 +0000" MODIFIED_BY="[Empty name]">
<P>RCT. Allocation concealment unclear; masking of participants and primary investigators not adequate, masking of outcome assessment adequate.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-04-05 05:36:43 +0100" MODIFIED_BY="[Empty name]">
<P>In Finland, 450 patients undergoing elective cataract extraction.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell">
<P>Three groups of patients: group 'R' received retrobulbar anaesthesia, group 'P1' periocular injection given inferotemporally and superonasally, group 'P11' periocular injection given inferotemporally and into the medial compartment of the orbit. All blocks were performed with a solution of 2% lidocaine with 1:100000 adrenaline and 0.5% bupivacaine with 75 IU hyaluronidase.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-03-17 14:52:29 +0000" MODIFIED_BY="Jane Cracknell">
<P>Extraocular muscle akinesia.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-03-11 10:33:00 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Athanikar-1991">
<CHAR_METHODS MODIFIED="2008-03-17 14:52:45 +0000" MODIFIED_BY="Jane Cracknell">
<P>RCT. Allocation by randomization chart, masking of participants and primary investigators was adequate.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-03-17 14:54:03 +0000" MODIFIED_BY="Jane Cracknell">
<P>In India, 142 patients undergoing cataract surgery.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-03-11 10:33:00 +0000" MODIFIED_BY="[Empty name]">
<P>Peribulbar anaesthesia (71) (5 cc of anaesthetic using a 3.75 cm needle placed at the junction of medial 2/3 and the lateral 1/3 of the inferior orbital rim and directed backwards and upwards) versus retrobulbar anaesthesia (71) (5 cc of anaesthetic agent injected with a 1.5 cm needle directed straight down, with the needle buried up to the hub at the skin). A mixture of lidocaine 2% + 1:200000 + hyaluronidase was used for both groups. No facial blocks or additional injection for lid akinesia. Pinky ball pressure was applied for 10 minutes. All injections were given with a mixture of 2% lidocaine, 1:200000 adrenaline and 150 IU hyaluronidase.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-04-05 05:41:28 +0100" MODIFIED_BY="[Empty name]">
<P>Lid akinesia and globe akinesia graded on a scale of 0 to +++, number of participants that developed complications.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-03-11 10:33:22 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Feibel-1993">
<CHAR_METHODS MODIFIED="2008-04-05 05:41:44 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Allocation concealment adequate; masking of participants and primary investigators adequate, masking of outcome assessment adequate.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-03-17 14:57:34 +0000" MODIFIED_BY="Jane Cracknell">
<P>In USA, 317 patients receiving cataract surgery.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-03-17 14:58:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>Two injection periocular anaesthesia versus retrobulbar anaesthesia. Anaesthetic injection consisted of 0.375% bupivacaine, 1% mepivacaine and hyaluronidase. No orbital compression was used.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-03-11 10:33:22 +0000" MODIFIED_BY="[Empty name]">
<P>Postcataract surgery ptosis.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-04-05 05:45:04 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Weiss-1989">
<CHAR_METHODS MODIFIED="2008-04-05 05:42:43 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Allocation concealment unclear; masking of participants and primary investigators adequate, masking of outcome assessment adequate.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-03-24 22:31:01 +0000" MODIFIED_BY="[Empty name]">
<P>79 consecutive patients that received cataract extraction with intraocular lens implants at the Mary Imogene Bassett Hospital, Cooperstown, NY.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-04-05 05:44:53 +0100" MODIFIED_BY="[Empty name]">
<P>Periocular anaesthesia versus retrobulbar anaesthesia, each patient received 0.5 to 1.0 mg of intravenous idazolam administered by ophthalmic resident, identical mixture of anaesthetic: 50:50 mixture of 2% lidocaine and 0.75% bupivacaine with 1:200000 epinephrine, honan pressure balloon set at 30 mm Hg was placed immediately following the administration of anaesthetic and left for 10 minutes.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-04-05 05:45:04 +0100" MODIFIED_BY="[Empty name]">
<P>Globe anaesthesia, glove akinesia, lid akinesia, supplemental blocks, complications.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-04-05 05:47:39 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wong-1993">
<CHAR_METHODS MODIFIED="2008-04-05 05:45:23 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Allocation concealment clear; masking of participants and primary investigators adequate, masking of outcome assessment adequate.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-04-05 05:45:49 +0100" MODIFIED_BY="[Empty name]">
<P>150 patients of one surgeon who were having cataract surgery at Vancouver General Hospital, Canada. Age range 21-95 years.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-04-05 05:47:21 +0100" MODIFIED_BY="[Empty name]">
<P>Retrobulbar block (50 patients): received 4 ml of anaesthetic; peribulbar block (50 patients): received 7 ml of anaesthetic; and modified retrobulbar block (50 patients): received 4.5 ml of anaesthetic.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-04-05 05:47:39 +0100" MODIFIED_BY="[Empty name]">
<P>Akinesia, analgesia, orbital pressure, block supplementation, complications, patient satisfaction.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2008-04-05 05:52:15 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2008-04-05 05:49:51 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Asensio-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-04-05 05:49:51 +0100" MODIFIED_BY="[Empty name]">
<P>Concealment of allocation was unclear; masking of participants and primary investigators and masking of outcome assessment were unclear.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-04-05 05:48:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Barker-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-04-05 05:48:57 +0100" MODIFIED_BY="[Empty name]">
<P>Not a study: a letter to the editor.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-03-17 15:02:13 +0000" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Edge-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-03-17 15:02:13 +0000" MODIFIED_BY="Jane Cracknell">
<P>Concealment of allocation was unclear, masking of participants and primary investigators and masking of outcome assessment were unclear.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-04-05 05:50:12 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hessemer-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-04-05 05:50:12 +0100" MODIFIED_BY="[Empty name]">
<P>Outcome measures not clearly stated. Did not report any of the outcome measures for this review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-03-17 15:02:20 +0000" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Jacobi-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-03-17 15:02:20 +0000" MODIFIED_BY="Jane Cracknell">
<P>The trial compared topical anaesthesia with retrobulbar anaesthesia in complicated cataract.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-03-17 15:02:23 +0000" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Lavinsky-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-03-17 15:02:23 +0000" MODIFIED_BY="Jane Cracknell">
<P>Concealment of allocation was unclear, masking of participants and primary investigators and masking of outcome assessment were unclear.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-03-17 15:02:28 +0000" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Murdoch-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-03-17 15:02:28 +0000" MODIFIED_BY="Jane Cracknell">
<P>Concealment of allocation inadequate, masking of participants and primary investigators inadequate and masking of outcome assessment unclear.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-04-05 05:51:28 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ramsay-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-04-05 05:51:28 +0100" MODIFIED_BY="[Empty name]">
<P>The study compared sub-tenons, peribulbar and retrobulbar anaesthesia. The outcome measures were not included in our review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-03-17 15:02:43 +0000" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Ropo-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-03-17 15:02:43 +0000" MODIFIED_BY="Jane Cracknell">
<P>The study objective is the effect of an anaesthetic agent on the optic nerve head.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-04-05 05:51:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sanford-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-04-05 05:51:53 +0100" MODIFIED_BY="[Empty name]">
<P>The study included participants who had trabeculectomy.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-03-17 15:02:48 +0000" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Saunders-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-03-17 15:02:48 +0000" MODIFIED_BY="Jane Cracknell">
<P>The outcome measure of the study was not relevant to our review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-04-05 05:52:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Whitsett-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-04-05 05:52:15 +0100" MODIFIED_BY="[Empty name]">
<P>Concealment allocation unclear; masking of participants and primary investigators unclear and masking of outcome assessment inadequate.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2011-03-03 13:35:46 +0000" MODIFIED_BY="Jane Cracknell" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2011-03-03 13:35:43 +0000" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Agrawal-1993">
<CHAR_METHODS MODIFIED="2008-04-05 05:52:40 +0100" MODIFIED_BY="[Empty name]">
<P>Double-blinded RCT.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-03-03 13:35:40 +0000" MODIFIED_BY="Jane Cracknell">
<P>122 patients eligible for intracapsular cataract extraction under local anaesthesia.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-04-05 05:53:06 +0100" MODIFIED_BY="[Empty name]">
<P>Peribulbar or retrobulbar anaesthesia; infiltrated with 5 ml of the same anaesthetic at the same site but with different needle size.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-03-03 13:35:43 +0000" MODIFIED_BY="Jane Cracknell">
<P>Globe anaesthesia (primary outcome), globe akinesia, lid akinesia, pupillary dilatation, and hypotony scored separately on a 4-point scale during surgery by a masked surgeon.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-04-05 05:53:40 +0100" MODIFIED_BY="[Empty name]">
<P>Unable to acquire full content paper.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2011-03-03 13:35:46 +0000" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Li-1996">
<CHAR_METHODS MODIFIED="2008-04-05 05:53:58 +0100" MODIFIED_BY="[Empty name]">
<P>Comparison.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-04-05 05:54:01 +0100" MODIFIED_BY="[Empty name]">
<P>Cataract surgery patients.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-03-03 13:35:46 +0000" MODIFIED_BY="Jane Cracknell">
<P>Retrobulbar and periocular anaesthesia.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-04-05 05:54:11 +0100" MODIFIED_BY="[Empty name]">
<P>Not clear from the available data.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-04-05 05:54:26 +0100" MODIFIED_BY="[Empty name]">
<P>Incomplete abstract. Need to get full content paper.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2008-04-05 05:55:08 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Meyer-1992">
<CHAR_METHODS MODIFIED="2008-04-05 05:54:49 +0100" MODIFIED_BY="[Empty name]">
<P>Prospective RCT, 79 patients undergoing elective routine cataract surgery using Kelman phacoemulsification technique. Group 1 (39 patients) received PB while group 2 (40 patients) received RB. Both groups received a total of 10.5 ml of local anaesthetic.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-04-05 05:54:59 +0100" MODIFIED_BY="[Empty name]">
<P>79 patients undergoing cataract surgery.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-04-05 05:55:05 +0100" MODIFIED_BY="[Empty name]">
<P>Peribulbar and retrobulbar anaesthesia.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-04-05 05:55:08 +0100" MODIFIED_BY="[Empty name]">
<P>Mean intraocular pressure elevation.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2008-04-05 05:56:08 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sanders-1997">
<CHAR_METHODS MODIFIED="2008-04-05 05:55:55 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Comparison of plasma catecholamine and pressor effects between the two methods of anaesthesia in 40 patients.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-04-05 05:55:58 +0100" MODIFIED_BY="[Empty name]">
<P>Cataract surgery patients.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-04-05 05:56:02 +0100" MODIFIED_BY="[Empty name]">
<P>Peribulbar and retrobulbar anaesthesia.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-04-05 05:56:08 +0100" MODIFIED_BY="[Empty name]">
<P>Plasma adrenaline and noradrenaline, heart rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2011-03-11 10:34:05 +0000" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2011-03-11 10:33:43 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-05 12:25:16 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ali_x002d_Melkkila-1992">
<DESCRIPTION>
<P>Sequence generation was not defined properly</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-13 03:48:27 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ali_x002d_Melkkila-1993">
<DESCRIPTION>
<P>Patients were divided into three groups in consecutive order </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-05 12:28:32 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Athanikar-1991">
<DESCRIPTION>
<P>By randomization chart</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-03 13:35:24 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Feibel-1993">
<DESCRIPTION>
<P>Randomization to retrobulbar or peribulbar injection was decided by coin toss</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-11 10:33:43 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Weiss-1989">
<DESCRIPTION>
<P>Patients were randomized as to whether they will receive retrobulbar or periocular anaesthesia. The method not clearly stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-12 04:48:58 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wong-1993">
<DESCRIPTION>
<P>Patients were randomly assigned by draw to one of the three blocks</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2011-03-11 10:34:05 +0000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-13 03:48:27 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ali_x002d_Melkkila-1992">
<DESCRIPTION>
<P>Patients were allocated randomly to receive either retrobulbar or periocular anaesthesia</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-05 12:56:54 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ali_x002d_Melkkila-1993">
<DESCRIPTION>
<P>Method of randomization not clearly stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-05 16:56:55 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Athanikar-1991">
<DESCRIPTION>
<P>The method of allocation concealment not clear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-04 10:39:50 +0000" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Feibel-1993">
<DESCRIPTION>
<P>The method of allocation was unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-13 03:48:27 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Weiss-1989">
<DESCRIPTION>
<P>No information given on the method of concealment allocation used in the trial</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-11 10:34:05 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wong-1993">
<DESCRIPTION>
<P>Allocation was by nurse drawing from an envelope</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-12-05 12:35:59 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ali_x002d_Melkkila-1992">
<DESCRIPTION>
<P>Blinding method was stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Ali_x002d_Melkkila-1993">
<DESCRIPTION>
<P>The outcome assessor was not aware of the type of anaesthesia administered</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-12-05 12:29:13 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Athanikar-1991">
<DESCRIPTION>
<P>Administration and evaluation done by separate person</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-12-05 12:47:24 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Feibel-1993">
<DESCRIPTION>
<P>Adiministrator of injection different from the assessor of ptosis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-12-05 12:52:04 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weiss-1989">
<DESCRIPTION>
<P>Anaesthetist administered the injection while the Surgeon did the assessment<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-12-05 06:16:34 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wong-1993">
<DESCRIPTION>
<P>Outcome assessor was not aware of the type of intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-09" LEVEL="GROUP" NO="9">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-10" LEVEL="GROUP" NO="10">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2010-11-18 18:36:24 +0000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2010-12-05 06:16:46 +0000" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-05 12:36:06 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ali_x002d_Melkkila-1992">
<DESCRIPTION>
<P>All data reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-05 12:57:32 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ali_x002d_Melkkila-1993">
<DESCRIPTION>
<P>All data reported on</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-05 12:29:46 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Athanikar-1991">
<DESCRIPTION>
<P>All data reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-05 12:47:38 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Feibel-1993">
<DESCRIPTION>
<P>All data reported on</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-05 12:52:12 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weiss-1989">
<DESCRIPTION>
<P>All data reported on</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-05 06:16:46 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wong-1993">
<DESCRIPTION>
<P>All data reported on</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2010-12-05 06:16:57 +0000" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-05 12:36:35 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ali_x002d_Melkkila-1992">
<DESCRIPTION>
<P>Free of publication bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-05 12:57:40 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ali_x002d_Melkkila-1993">
<DESCRIPTION>
<P>Free of publication bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-05 12:58:16 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Athanikar-1991">
<DESCRIPTION>
<P>Free of publication bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-05 12:47:56 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Feibel-1993">
<DESCRIPTION>
<P>Free of publication bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-05 12:52:24 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weiss-1989">
<DESCRIPTION>
<P>Free of publication bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-05 06:16:57 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wong-1993">
<DESCRIPTION>
<P>Free of publication bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Performance: blinding during study</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Detection: blind outcome assessment</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2011-02-07 02:50:50 +0000" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2011-02-07 02:50:50 +0000" MODIFIED_BY="Grade Profiler" NO="1" READONLY="YES">
<TITLE MODIFIED="2011-02-07 02:50:50 +0000" MODIFIED_BY="Grade Profiler">Peribulbar versus retrobulbar for cataract surgery</TITLE>
<TABLE COLS="7" ROWS="9">
<TR>
<TD COLSPAN="7">
<P>
<B>Peribulbar versus retrobulbar for cataract surgery</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> patients with cataract surgery<BR/>
<B>Settings:</B> Hospital or Ambulatory cataract surgery services<BR/>
<B>Intervention:</B> Peribulbar versus retrobulbar<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Control</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Peribulbar versus retrobulbar</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Pain score</B>
<BR/>none<SUP>1</SUP>. Scale from: 0 to 4.</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean pain score in the control groups was<BR/>
<B> scale (0 to 4)</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean Pain score in the intervention groups was<BR/>
<B>0.03 lower</B>
<BR/>(0.17 lower to 0.11 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>221<BR/>(2 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Globe akinesia</B>
<BR/>extraocular muscle motility</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 0.96 </B>
<BR/>(0.82 to 1.13)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>1042<BR/>(4 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>787 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>756 per 1000</B>
<BR/>(645 to 889)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Medium risk population</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>808 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>776 per 1000</B>
<BR/>(663 to 913)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Need for additional injection</B>
<BR/>Number of additional injections</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 1.54 </B>
<BR/>(0.91 to 2.6)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>1029<BR/>(4 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>127 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>196 per 1000</B>
<BR/>(116 to 330)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Medium risk population</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>123 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>189 per 1000</B>
<BR/>(112 to 320)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Local complications - Retrobular haemorrhage</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 0.33 </B>
<BR/>(0.01 to 8.05)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>142<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>14 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>5 per 1000</B>
<BR/>(0 to 113)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Medium risk population</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>14 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>5 per 1000</B>
<BR/>(0 to 113)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Local complications - Conjunctival chemosis</B>
<BR/>presence of conjunctival chemosis</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 2.11 </B>
<BR/>(1.46 to 3.05)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>1042<BR/>(4 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>71 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>150 per 1000</B>
<BR/>(104 to 217)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Medium risk population</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>56 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>118 per 1000</B>
<BR/>(82 to 171)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Local complications - Ptosis</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 1.06 </B>
<BR/>(0.43 to 2.6)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>317<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>5</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>55 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>58 per 1000</B>
<BR/>(24 to 143)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Medium risk population</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>55 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>58 per 1000</B>
<BR/>(24 to 143)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Acceptability of blocks</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 1.01 </B>
<BR/>(0.98 to 1.03)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>600<BR/>(2 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>968 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>978 per 1000</B>
<BR/>(949 to 997)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Medium risk population</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>965 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>975 per 1000</B>
<BR/>(946 to 994)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>RR:</B> Risk ratio; </P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect. <BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> on a scale of 0 to 4<BR/>
<SUP>2</SUP> Sequence generation and allocation concealment was inadequate <BR/>
<SUP>3</SUP> Allocation concealment and sequence generation not clear<BR/>
<SUP>4</SUP> Allocation concealment and masking was not adequate in 2 of the four trials<BR/>
<SUP>5</SUP> Sequence generation not clear</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2008-03-17 13:58:24 +0000" MODIFIED_BY="Jane Cracknell"/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2008-03-26 14:24:16 +0000" MODIFIED_BY="Jane Cracknell">
<COMPARISON ID="CMP-001" MODIFIED="2008-03-26 14:24:16 +0000" MODIFIED_BY="Jane Cracknell" NO="1">
<NAME>Peribulbar versus retrobulbar</NAME>
<CONT_OUTCOME CHI2="0.6311225071879792" CI_END="0.10582278805167998" CI_START="-0.1695741803000675" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.03187569612419376" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.01" MODIFIED="2008-02-10 05:26:18 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.4269440953086826" P_Q="1.0" P_Z="0.6500373757491154" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="110" TOTAL_2="111" UNITS="" WEIGHT="100.0" Z="0.4537102696480453">
<NAME>Pain score</NAME>
<GROUP_LABEL_1>Peribulbar</GROUP_LABEL_1>
<GROUP_LABEL_2>Retrobulbar</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Peribulbar</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Retrobulbar</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.09477671721308889" CI_START="-0.19477671721308853" EFFECT_SIZE="-0.04999999999999982" ESTIMABLE="YES" MEAN_1="3.71" MEAN_2="3.76" ORDER="2" SD_1="0.45" SD_2="0.43" SE="0.07386702937149303" STUDY_ID="STD-Athanikar-1991" TOTAL_1="71" TOTAL_2="71" WEIGHT="90.46089269694416"/>
<CONT_DATA CI_END="0.5858361630077236" CI_START="-0.3058361630077242" EFFECT_SIZE="0.13999999999999968" ESTIMABLE="YES" MEAN_1="3.26" MEAN_2="3.12" ORDER="1" SD_1="1.04" SD_2="0.98" SE="0.2274716099501943" STUDY_ID="STD-Weiss-1989" TOTAL_1="39" TOTAL_2="40" WEIGHT="9.539107303055847"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="15.9433882048115" CI_END="1.0884547830907634" CI_START="0.8785860768924427" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9779065485773825" ESTIMABLE="YES" EVENTS_1="416" EVENTS_2="377" I2="81.18342248547495" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.0368103921625454" LOG_CI_START="-0.056215683356943096" LOG_EFFECT_SIZE="-0.009702645597198854" METHOD="MH" MODIFIED="2008-02-10 05:49:43 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.001164699224952992" P_Q="1.0" P_Z="0.6826500538001089" Q="0.0" RANDOM="YES" SCALE="2.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.008863226860161612" TOTALS="YES" TOTAL_1="563" TOTAL_2="479" WEIGHT="100.00000000000003" Z="0.4088495794124293">
<NAME>Globe akinesia</NAME>
<GROUP_LABEL_1>Peribulbar</GROUP_LABEL_1>
<GROUP_LABEL_2>Retrobulbar</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Retrobulbar</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Peribulbar</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.9445765884871737" CI_START="0.6540768259884403" EFFECT_SIZE="0.7860188654864969" ESTIMABLE="YES" EVENTS_1="77" EVENTS_2="109" LOG_CI_END="-0.02476282269837669" LOG_CI_START="-0.1843712376951746" LOG_EFFECT_SIZE="-0.10456703019677566" ORDER="4" O_E="0.0" SE="0.0937547730435155" STUDY_ID="STD-Ali_x002d_Melkkila-1992" TOTAL_1="142" TOTAL_2="158" VAR="0.0087899574684411" WEIGHT="16.914592822180808"/>
<DICH_DATA CI_END="1.1792706538808704" CI_START="0.9215084761009973" EFFECT_SIZE="1.0424528301886793" ESTIMABLE="YES" EVENTS_1="221" EVENTS_2="106" LOG_CI_END="0.07161349126748869" LOG_CI_START="-0.0355006657547701" LOG_EFFECT_SIZE="0.01805641275635928" ORDER="5" O_E="0.0" SE="0.06291938605850343" STUDY_ID="STD-Ali_x002d_Melkkila-1993" TOTAL_1="300" TOTAL_2="150" VAR="0.003958849141978996" WEIGHT="23.287681720445917"/>
<DICH_DATA CI_END="1.027693259732438" CI_START="0.9730529907925561" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="71" EVENTS_2="71" LOG_CI_END="0.01186350815698553" LOG_CI_START="-0.011863508156985544" LOG_EFFECT_SIZE="0.0" ORDER="3" O_E="0.0" SE="0.013937366833451568" STUDY_ID="STD-Athanikar-1991" TOTAL_1="71" TOTAL_2="71" VAR="1.9425019425019577E-4" WEIGHT="32.96684309984254"/>
<DICH_DATA CI_END="1.1339718778671006" CI_START="0.9409588650502392" EFFECT_SIZE="1.032967032967033" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="91" LOG_CI_END="0.05460228432886391" LOG_CI_START="-0.02642936177165376" LOG_EFFECT_SIZE="0.014086461278605104" ORDER="6" O_E="0.0" SE="0.047598390032561375" STUDY_ID="STD-Wong-1993" TOTAL_1="50" TOTAL_2="100" VAR="0.002265606733691838" WEIGHT="26.83088235753075"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="7.940029360489217" CI_END="2.5952132938424377" CI_START="0.9126933688077223" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="1.5390366999950456" ESTIMABLE="YES" EVENTS_1="110" EVENTS_2="63" I2="62.21676439978355" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.41417305718720676" LOG_CI_START="-0.039675104833806187" LOG_EFFECT_SIZE="0.18724897617670028" METHOD="MH" MODIFIED="2008-02-10 05:34:26 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.04726761644257271" P_Q="1.0" P_Z="0.1058164551292039" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.17015671212010786" TOTALS="YES" TOTAL_1="531" TOTAL_2="498" WEIGHT="100.0" Z="1.61728648548031">
<NAME>Need for additional injection</NAME>
<GROUP_LABEL_1>Peribulbar</GROUP_LABEL_1>
<GROUP_LABEL_2>Retrobulbar</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Peribulbar</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Retrobulbar</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.4347305332131" CI_START="1.7448185367123963" EFFECT_SIZE="2.7816901408450705" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="20" LOG_CI_END="0.646867236006751" LOG_CI_START="0.24175026648005643" LOG_EFFECT_SIZE="0.44430875124340374" ORDER="7" O_E="0.0" SE="0.23796771326132168" STUDY_ID="STD-Ali_x002d_Melkkila-1992" TOTAL_1="142" TOTAL_2="158" VAR="0.05662863255482261" WEIGHT="31.338729072027785"/>
<DICH_DATA CI_END="2.039752659015114" CI_START="0.7323570109795152" EFFECT_SIZE="1.2222222222222223" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="18" LOG_CI_END="0.3095775079467616" LOG_CI_START="-0.13527715650896124" LOG_EFFECT_SIZE="0.0871501757189002" ORDER="8" O_E="0.0" SE="0.26130983196739516" STUDY_ID="STD-Ali_x002d_Melkkila-1993" TOTAL_1="300" TOTAL_2="150" VAR="0.06828282828282829" WEIGHT="29.80698781025904"/>
<DICH_DATA CI_END="3.128517128141969" CI_START="0.6357079284556968" EFFECT_SIZE="1.4102564102564104" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="8" LOG_CI_END="0.4953385370144126" LOG_CI_START="-0.19674237207892323" LOG_EFFECT_SIZE="0.14929808246774467" ORDER="9" O_E="0.0" SE="0.40653175185717694" STUDY_ID="STD-Weiss-1989" TOTAL_1="39" TOTAL_2="40" VAR="0.16526806526806528" WEIGHT="21.188549425641447"/>
<DICH_DATA CI_END="2.2686833020761927" CI_START="0.3431711742623039" EFFECT_SIZE="0.8823529411764706" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="17" LOG_CI_END="0.3557738745714564" LOG_CI_START="-0.4644891992166418" LOG_EFFECT_SIZE="-0.0543576623225927" ORDER="10" O_E="0.0" SE="0.4818265899108289" STUDY_ID="STD-Wong-1993" TOTAL_1="50" TOTAL_2="150" VAR="0.23215686274509809" WEIGHT="17.66573369207172"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="17.520732478735514" CI_END="2.0480780659741575" CI_START="1.1189996421917527" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="1.5138687601657745" ESTIMABLE="YES" EVENTS_1="115" EVENTS_2="55" I2="65.75485638353275" I2_Q="79.32485996487581" ID="CMP-001.04" LOG_CI_END="0.31134650649112017" LOG_CI_START="0.04882994765956344" LOG_EFFECT_SIZE="0.18008822707534183" METHOD="MH" MODIFIED="2008-03-26 14:24:16 +0000" MODIFIED_BY="Jane Cracknell" NO="4" P_CHI2="0.007548479169280697" P_Q="0.0022869008192842877" P_Z="0.0071645280379285334" Q="14.51017983386529" RANDOM="NO" SCALE="291.059502072487" SORT_BY="EFFECT_SIZE" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="1088" TOTAL_2="863" WEIGHT="400.0" Z="2.6890984757561247">
<NAME>Local complications</NAME>
<GROUP_LABEL_1>Peribulbar</GROUP_LABEL_1>
<GROUP_LABEL_2>Retrobubar</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Peribulbar</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Retrobulbar</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="8.046860575602167" CI_START="0.013808007491517449" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-001.04.01" LOG_CI_END="0.905626476563541" LOG_CI_START="-1.8598689860028657" LOG_EFFECT_SIZE="-0.47712125471966244" NO="1" P_CHI2="1.0" P_Z="0.49885562122465" STUDIES="1" TAU2="0.0" TOTAL_1="71" TOTAL_2="71" WEIGHT="100.0" Z="0.6762914553049242">
<NAME>Retrobular haemorrhage</NAME>
<DICH_DATA CI_END="8.046860575602167" CI_START="0.013808007491517449" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.905626476563541" LOG_CI_START="-1.8598689860028657" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="11" O_E="0.0" SE="1.6244657241348273" STUDY_ID="STD-Athanikar-1991" TOTAL_1="71" TOTAL_2="71" VAR="2.638888888888889" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.40493613002376" CI_END="3.054296713334097" CI_START="1.4623910112054765" DF="3" EFFECT_SIZE="2.113427561837456" ESTIMABLE="YES" EVENTS_1="98" EVENTS_2="34" I2="31.89458572277146" ID="CMP-001.04.02" LOG_CI_END="0.4849112248305288" LOG_CI_START="0.1650635089451049" LOG_EFFECT_SIZE="0.3249873668878168" NO="2" P_CHI2="0.22092836936692872" P_Z="6.807438814498252E-5" STUDIES="4" TAU2="0.0" TOTAL_1="563" TOTAL_2="479" WEIGHT="99.99999999999999" Z="3.9829175129004186">
<NAME>Conjunctival chemosis</NAME>
<DICH_DATA CI_END="2.5773570889647734" CI_START="1.0245475923014762" EFFECT_SIZE="1.625" ESTIMABLE="YES" EVENTS_1="65" EVENTS_2="20" LOG_CI_END="0.41117459356963976" LOG_CI_START="0.01053213706014662" LOG_EFFECT_SIZE="0.21085336531489318" ORDER="13" O_E="0.0" SE="0.23533936216582085" STUDY_ID="STD-Ali_x002d_Melkkila-1993" TOTAL_1="300" TOTAL_2="150" VAR="0.055384615384615386" WEIGHT="70.67137809187278"/>
<DICH_DATA CI_END="5.015092052791407" CI_START="0.7975925382613056" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="8" LOG_CI_END="0.7002789089720797" LOG_CI_START="-0.09821891764411726" LOG_EFFECT_SIZE="0.3010299956639812" ORDER="15" O_E="0.0" SE="0.469041575982343" STUDY_ID="STD-Wong-1993" TOTAL_1="50" TOTAL_2="100" VAR="0.22" WEIGHT="14.134275618374556"/>
<DICH_DATA CI_END="8.432016819184359" CI_START="1.1511239336814802" EFFECT_SIZE="3.1154929577464787" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="5" LOG_CI_END="0.9259314641483186" LOG_CI_START="0.06112208367885202" LOG_EFFECT_SIZE="0.49352677391358535" ORDER="12" O_E="0.0" SE="0.5079933109632391" STUDY_ID="STD-Ali_x002d_Melkkila-1992" TOTAL_1="142" TOTAL_2="158" VAR="0.2580572039833941" WEIGHT="12.544169611307419"/>
<DICH_DATA CI_END="82.96411284507076" CI_START="1.4584619283033675" EFFECT_SIZE="11.0" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="1" LOG_CI_END="1.9188902735358113" LOG_CI_START="0.16389509678063913" LOG_EFFECT_SIZE="1.0413926851582251" ORDER="14" O_E="0.0" SE="1.030892854192221" STUDY_ID="STD-Athanikar-1991" TOTAL_1="71" TOTAL_2="71" VAR="1.0627400768245838" WEIGHT="2.6501766784452294"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.88495011872033" CI_START="0.1494224388035442" DF="0" EFFECT_SIZE="0.36363636363636365" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="11" I2="0.0" ID="CMP-001.04.03" LOG_CI_END="-0.05308120814402164" LOG_CI_START="-0.8255841795165036" LOG_EFFECT_SIZE="-0.43933269383026263" MODIFIED="2008-03-26 14:24:16 +0000" MODIFIED_BY="Jane Cracknell" NO="3" P_CHI2="1.0" P_Z="0.025792948764124055" STUDIES="1" TAU2="0.0" TOTAL_1="300" TOTAL_2="150" WEIGHT="100.0" Z="2.2293150681567733">
<NAME>Lid haematoma</NAME>
<DICH_DATA CI_END="0.8849501187203301" CI_START="0.1494224388035442" EFFECT_SIZE="0.36363636363636365" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="11" LOG_CI_END="-0.053081208144021584" LOG_CI_START="-0.8255841795165036" LOG_EFFECT_SIZE="-0.43933269383026263" ORDER="16" O_E="0.0" SE="0.4537720693355762" STUDY_ID="STD-Ali_x002d_Melkkila-1993" TOTAL_1="300" TOTAL_2="150" VAR="0.20590909090909093" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.5963243622374588" CI_START="0.4314940571103162" DF="0" EFFECT_SIZE="1.0584415584415585" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" I2="0.0" ID="CMP-001.04.04" LOG_CI_END="0.4143589485019993" LOG_CI_START="-0.3650251813670097" LOG_EFFECT_SIZE="0.02466688356749477" MODIFIED="2008-03-26 14:24:16 +0000" MODIFIED_BY="Jane Cracknell" NO="4" P_CHI2="1.0" P_Z="0.9012657252071014" STUDIES="1" TAU2="0.0" TOTAL_1="154" TOTAL_2="163" WEIGHT="100.0" Z="0.12406258108247133">
<NAME>Ptosis</NAME>
<DICH_DATA CI_END="2.5963243622374588" CI_START="0.4314940571103162" EFFECT_SIZE="1.0584415584415585" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.4143589485019993" LOG_CI_START="-0.3650251813670097" LOG_EFFECT_SIZE="0.02466688356749477" ORDER="17" O_E="0.0" SE="0.45781409589871996" STUDY_ID="STD-Feibel-1993" TOTAL_1="154" TOTAL_2="163" VAR="0.20959374640356235" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.546997882997592" CI_END="1.0344645362566534" CI_START="0.9766494401808259" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.005141388174807" ESTIMABLE="YES" EVENTS_1="345" EVENTS_2="242" I2="35.35867042931458" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="0.014715606676917771" LOG_CI_START="-0.010261294536599748" LOG_EFFECT_SIZE="0.002227156070158997" METHOD="MH" MODIFIED="2008-02-10 05:46:43 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.21357965659619738" P_Q="1.0" P_Z="0.7266879945599027" Q="0.0" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="350" TOTAL_2="250" WEIGHT="100.0" Z="0.34953460784790846">
<NAME>Acceptability of blocks</NAME>
<GROUP_LABEL_1>Peribulbar</GROUP_LABEL_1>
<GROUP_LABEL_2>Retrobulbar</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Retrobulbar</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Peribulbar</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.0414807348732864" CI_START="0.9931079876449286" EFFECT_SIZE="1.0170068027210883" ESTIMABLE="YES" EVENTS_1="299" EVENTS_2="147" LOG_CI_END="0.017651240855432817" LOG_CI_START="-0.0030035250308881227" LOG_EFFECT_SIZE="0.007323857912272315" ORDER="19" O_E="0.0" SE="0.012132711724364992" STUDY_ID="STD-Ali_x002d_Melkkila-1993" TOTAL_1="300" TOTAL_2="150" VAR="1.4720269378654376E-4" WEIGHT="75.57840616966581"/>
<DICH_DATA CI_END="1.0631109952817015" CI_START="0.8821650226010016" EFFECT_SIZE="0.968421052631579" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="95" LOG_CI_END="0.02657860988721334" LOG_CI_START="-0.054450165773798284" LOG_EFFECT_SIZE="-0.013935777943292491" ORDER="18" O_E="0.0" SE="0.04759670392218656" STUDY_ID="STD-Wong-1993" TOTAL_1="50" TOTAL_2="100" VAR="0.0022654462242562897" WEIGHT="24.421593830334192"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2015-05-01 21:44:42 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Additional_Figure[1]-2015-carg 046.doc.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2015-05-01 21:44:42 +0100" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAZIAAAO0CAYAAACP6LD4AABjSElEQVR42u29D2SX3////yFJksTM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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2015-05-01 21:42:49 +0100" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAiMAAADOCAMAAADbsfL2AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2015-05-01 21:42:49 +0100" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAQsAAAHOCAIAAAAAErsCAAASkklEQVR42u3dv67dRBfG4S0hIYoU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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2015-06-11 01:57:35 +0100" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2015-06-11 01:56:52 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2015-06-11 01:56:52 +0100" MODIFIED_BY="[Empty name]">
<I>The Central March 2015</I>
</TITLE>
<APPENDIX_BODY MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell">
<P>#1 MeSH descriptor Anesthesia, Conduction, this term only<BR/>#2 ((regional or local or peribulbar or retrobulbar or peri-bulbar or retro-bulbar or intraconal or periocular or intra-conal or peri-ocular) and anesthe*) <BR/>#3 ((regional or local or peribulbar or retrobulbar or peri-bulbar or retro-bulbar or intraconal or periocular or intra-conal or peri-ocular) and block*) <BR/>#4 (#1 OR #2 OR #3)<BR/>#5 MeSH descriptor Lens Implantation, Intraocular explode all trees<BR/>#6 MeSH descriptor Lenses, Intraocular explode all trees<BR/>#7 MeSH descriptor Cataract Extraction explode all trees<BR/>#8 (cataract* near extract*) <BR/>#9 (cataract* near surgery)<BR/>#10 (senile near cataract*)<BR/>#11 (age-related near cataract*)<BR/>#12 halogenous<BR/>#13 (#5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12)<BR/>#14 (#4 AND #13)<BR/>
<BR/>
</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2015-06-11 01:57:12 +0100" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2015-06-11 01:57:12 +0100" MODIFIED_BY="[Empty name]">Ovid MEDLINE (1960 to March 2015)</TITLE>
<APPENDIX_BODY MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell">
<P>1. exp Cataract-extraction/ or Lens-implantation-intraocular/ or LENSES/ or LENSES-INTRAOCULAR/ or (cataract* and (surgery or extract* or senile or age?related)).mp. or cataract*.ti,ab. or halogenous.mp.<BR/>2. exp Anesthesia-Conduction/ or ((regional or local or peri?bulbar or retro?bulbar or intra?conal or peri?ocular) and (an?esthe* or block*)).mp.<BR/>3. 1 and 2<BR/>4. ((randomized controlled trial or controlled clinical trial).pt. or randomized.ab. or placebo.ab. or drug therapy.fs. or randomly.ab. or trial.ab. or groups.ab.) not (animals not (humans and animals)).sh.<BR/>5. 3 and 4</P>
<P>
<BR/>
</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2015-06-11 01:57:35 +0100" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2015-06-11 01:57:35 +0100" MODIFIED_BY="[Empty name]">Ovid EMBASE (1980 to March 2015)</TITLE>
<APPENDIX_BODY MODIFIED="2010-12-13 10:06:25 +0000" MODIFIED_BY="Jane Cracknell">
<P>1. exp regional-anesthesia/ or ((regional or local or peri?bulbar or retro?bulbar or intra?conal or peri?ocular) and (an?esthe* or block*)).mp. <BR/>2. exp cataract-extraction/ or exp lens-implant/ or lens-implantation/ or lens-/ or lens-implant/ or (cataract* and (surgery or extract* or senile or age?related)).mp. or cataract*.ti,ab. or halogenous.mp. <BR/>3. 1 and 2 <BR/>4. (randomized-controlled-trial/ or randomization/ or controlled-study/ or multicenter-study/ or phase-3-clinical-trial/ or phase-4-clinical-trial/ or double-blind-procedure/ or single-blind-procedure/ or (random* or cross?over* or factorial* or placebo* or volunteer* or ((singl* or doubl* or trebl* or tripl*) adj3 (blind* or mask*))).ti,ab.) not (animals not (humans and animals)).sh. <BR/>5. 3 and 4 </P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;# of studies included in quantitative synthesis (meta-analysis) &lt;b&gt;6&lt;/b&gt;&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;# of full-text articles assessed for eligibility &lt;b&gt;18&lt;/b&gt;&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;# of records screened &lt;b&gt;871&lt;/b&gt;&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;# of records after duplicates removed &lt;b&gt;871&lt;/b&gt;&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;# of records identified through database searching &lt;b&gt;886&lt;/b&gt;&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;# of additional records identified through other sources &lt;b&gt;None&lt;/b&gt;&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;# of records excluded &lt;b&gt;853&lt;/b&gt;&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;# of full-text articles excluded, with reasons &lt;b&gt;12&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Intervention not necessary &lt;b&gt;2&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;Outcome message not applicable 2&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;Inadequate methodology 5&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;Not RCT 1&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;Non cataract participants included 1&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;Outcome message not measured 1&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>